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A saccular intracranial aneurysm (IA) is a pathological pouch 
from an intracranial artery. Its rupture causes subarachnoid 
hemorrhage (SAH), an acute intracranial bleeding with high 
mortality (30-40%) and morbidity. Unruptured IAs are common 
in the population (2-3%), but their rupture rate escapes prediction. 
Clinical risk factors for IA formation and rupture are smoking, 
female sex, and hypertension. Hypercholesterolemia, a risk factor 
for atherosclerosis, plays an unknown role in IAs. IA walls show 
multiple histological changes that resemble those in atherosclerotic 
lesions. These include chronic inflammation, structural artery wall 
remodeling, mural cell proliferation and death, loss of endothelium, 
intraluminal thrombosis, and lipid accumulation. Non-physiological 
blood-flow conditions in the artery lumen can trigger arterial wall 
remodeling and are hypothesized to contribute to IA pathogenesis. 
The potential role of atherogenic mechanisms in IA pathobiology 
remains, however, unestablished. The aim of this thesis was thus to 
discover the role of atherosclerotic and flow-related inflammatory 
changes as a potential trigger of IA wall rupture and to discuss 
potential tools for imaging those changes. 
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Methods
In total, 55 (25 unruptured and 30 ruptured) intraoperatively 
resected IA fundus specimens were the focus. The role of 
atherosclerotic and other histopathological changes in the IA 
walls were evaluated by histological and immunohistochemical 
methods. Of the 55 IAs, 36 underwent analysis for wall degenerative 
remodeling, neovascularization, and proinflammatory and 
proatherogenic factors such as the presence of apolipoproteins, 
oxidized lipids, erythrocyte remnants, and infiltrations of CD163+ 
and CD68+ macrophages, CD3+ T lymphocytes, and mast cells (MCs). 
Preoperative CT-angiography images provided the data source 
for hemodynamic simulations, which were then compared with 
histology in a subseries of 20 of the IAs. To correlate IA wall changes 
with MRI, 11 additional IAs underwent 4.7T MRI ex vivo, prior to 
their histological evaluation.
Results and Discussion
Aneurysm rupture status or degenerative wall changes did not 
associate in the series of 55 IAs with clinical parameters such as 
patient sex, age, hypertension or smoking status. 
The 36 (16 unruptured and 20 ruptured) IAs studied for histology 
showed extensive degenerative remodeling changes, similarly 
to changes in earlier studies. All IAs showed accumulation of 
lipids, the apolipoproteins A-I and B-100 of high- and low-density 
lipoproteins (HDL and LDL), reflecting atherogenic processes in the 
IA walls. These changes occurred independent of plasma lipid levels. 
Extensive lipid accumulation correlated with the infiltration of all 
the inflammatory-cell subtypes, suggesting the proinflammatory 
potential in the IA wall of lipids. Foam cell formation in a-smooth 
muscle cells and macrophages and their expression of adenosine 
triphosphate-binding cassette A1 (ABCA-1) indicated lipid 
clearance by these cells and via the ABCA-1 – apoA-I pathway. The 
extracellular load of neutral lipids and adipophilin, a marker of 
lipid intake, reflected potential insufficient cellular lipid clearance 
and subsequent foam-cell death from their excess lipid-load in 
degenerated and ruptured IAs.
In addition to their extensive, potentially LDL-derived lipid load, 
another source of lipids in the IA wall appeared to be cholesterol-
rich erythrocytes, because their membrane-protein glycophorin 
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A (GPA) massively accumulated in degenerated and ruptured 
IAs. Importantly, the presence of GPA in all layers of the IA walls 
and in the organized (old) intraluminal thrombus suggested that 
erythrocytes in the IA wall do not originate from the rupture, 
but rather represent a chronic accumulation. Subjected to lysis, 
erythrocytes release hemoglobin, a potent oxidant because of its 
iron-containing heme. The presence of oxidized lipids in the IA wall 
re ected the existence of this oxidative stress. 
In ltration of CD163+/HLA-DR- (human leukocyte antigen-DR) 
phagocytes in the IA wall suggests the presence of a hemorrhage-
associated macrophage phenotype previously described in 
coronary atherosclerotic lesions and abdominal aortic aneurysms. 
This nding thus suggests the role of a similar atheroprotective 
macrophage population in the IA wall, potentially specialized in 
hemoglobin clearance. Hemosiderin, a lysosomally generated 
product of hemoglobin, was deposited adjacent to adventitial 
neovessels, interpreted as sources of intramural microhemorrhages. 
Pro-oxidative hemoglobin may play a role in the regulation of 
in ammatory response in IA wall degeneration, pushing towards the 
wall’s eventual rupture.
Ex vivo MRI provided signal-intensity changes associated with 
GPA and hemosiderin in histology. However, an iron-associated 
signal void, once spatially demonstrated in giant human IAs, was 
not visible in the present series of small IAs. Flow models of IAs 
showed the association of low and high wall shear-stress levels with 
IA wall in ammation and remodeling, suggesting that hemodynamic 
simulations, as well, could serve as a tool in detection of rupture-
prone human IA walls.
Conclusion
Aneurysm walls show a variety of degenerative remodeling 
changes similar to those in extracranial atherosclerosis, changes 
which may predispose to IA wall rupture. Experimental models 
are warranted to verify the suggested mechanisms. Nevertheless, 
the present study provides important clari cation of IA-wall 
pathogenesis which may prove useful in development of preventive 
treatment for low-risk IAs and better diagnostic methods to reveal 
high-risk IAs.
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Aivovaltimoaneurysma (AA) on kallonpohjan valtimon 
sairaus, jossa tyypillisesti lähelle valtimon haarautumiskohtaa 
verisuonen seinämästä muodostuu pussimainen uloke, 
aneurysma. AA on sekä Suomessa että maailmalla yleinen: 
sen kantajia arvioidaan olevan väestöstä 2-3%. Tunnettuja 
riskitekijöitä ovat tupakointi, naissukupuoli ja korkea verenpaine. 
Puhkeamaton AA ei yleensä aiheuta kantajalleen oireita, mutta 
AA:n puhkeaminen johtaa vaaralliseen lukinkalvonalaiseen 
aivoverenvuotoon (subaraknoidaalivuoto). Vuodon saaneista 
lähes puolet kuolee (30-40%), ja hengissä selvinneistä moni 
vammautuu. AA voidaan eristää verenkierrosta sulkemalla AA:n 
tyvi joko avoleikkauksessa (klipsaus) tai verisuonen sisältä käsin 
(koilaus ja/tai stenttaus). AA:n hoitovaihtoehdot sisältävät 
riskejä, eikä kaikkia AA:a tarvitse hoitaa toimenpiteillä - kaikki 
AA:t eivät puhkea ihmiselämän aikana. Puhkeamisvaarassa olevaa 
AA:a ei kuitenkaan osata tunnistaa riittävällä varmuudella. Oikea-
aikaisen hoidon kohdentamiseksi olisi ymmärrettävä, miksi AA 
puhkeaa.
Tiedetään, että puhjenneen AA:n seinämä on yleensä pitkälle 
rappeutunut. Rappeutuneissa AA:ssa jyllää krooninen tulehdus 
ja seinämän rakenne on muuntunut. Normaalin valtimon 
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seinämästä pääosan muodostaa yhtenäinen sileälihaskerros; 
AA:ssa todetaan sekä sileälihassolujen katoa että näiden 
lisääntymistä ja yleistä epäjärjestystä. Merkkinä valtimon 
sisäpintaa verhoavan endoteelin vauriosta AA-pussin sisäpinnalle 
on usein muodostunut verihyytymää, joka on ajan kuluessa voinut 
sulautua osaksi itse AA:n seinämää. Sairaaseen AA:n seinämään 
kertyy lisäksi rasvaa. AA:n seinämämuutokset muistuttavatkin 
kudostasolla valtimotaudin (ateroskleroosin) vaurioittamaa 
verisuonen seinämää. Näiden muutosten yhteyttä AA:n seinämän 
rappeutumiseen ei tunneta. Sekä ateroskleroosin että AA:n 
tyyppisijainti valtimon haarautumiskohdassa on osaltaan 
aiheuttanut epäilyä paikallisten veren virtausolosuhteiden 
kuluttavasta vaikutuksesta valtimon seinämään. Näitä vaikutuksia 
AA:n kudostason rappeutumiseen ei kuitenkaan tunneta. Myös 
ateroskleroottisten verisuonen seinämämuutosten vaikutus AA:n 
rappeutumiseen on tuntematon. 
Tässä tutkimuksessa selvitettiin AA:n seinämän 
ateroskleroottisten muutosten sekä veren virtausolosuhteiden 
vaikutusta AA:n seinämän tulehdukseen, rappeutumiseen ja 
puhkeamiseen. Lisäksi selvitettiin muutosten kuvannettavuutta 
kokeellisella magneettikuvaustekniikalla. 
Menetelmät
Työssä tutkittiin AA-leikkauksessa klipsattuja ja 
irroitettuja AA:n seinämänäytteitä: yhteensä 55 AA:aa, 25 
puhkeamatonta ja 30 puhjennutta. AA:n seinämän kudosta 
tutkittiin ohutleikkeiltä immunohistokemiallisin ja histologisin 
värjäyksin. AA:n seinämien rakenteellista rappeutumista 
kuvattiin aiemmin käytetyllä seinämätyyppiluokittelulla (ABCD). 
36 AA:n seinämästä (16 puhkeamatonta ja 20 puhjennutta) 
etsittiin uudisverisuonitusta ja erilaisia tulehdussoluja sekä 
rasva- ja punasolujätettä. 20 AA:sta tehtiin matemaattinen 
mallinnus verenvirtausolosuhteista ennen leikkausta otettujen 
tietokonetomografiakuvien perusteella, ja virtausolosuhteita 
verrattiin AA:n kudostason muutoksiin. 11 AA:aa kuvannettiin 
koeputkessa magneettikuvauslaitteella, ja magneettikuvia 
verrattiin AA:n seinämien kudostason näkymiin.
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Tulokset ja Pohdinta
Tässä näytesarjassa AA-potilaan ikä, sukupuoli, ajankohtainen 
tupakointi, tiedossa oleva verenpainetauti tai kolesteroliarvot eivät 
liittyneet AA:n puhkeamiseen tai seinämämuutoksiin. Tutkitussa 36 
AA:n sarjassa AA:n seinämistä 9 olivat sileälihassolukerrokseltaan 
järjestyneitä ja endoteeliltaan hyvin säilyneitä muistuttaen normaalia 
valtimonseinämää (tyyppi A), 12:ssa seinämä oli paksuuntunut ja 
sileälihassolut olivat epäjärjestyksessä (tyyppi B), 11:ssa rappeutunut 
seinämä sisälsi alueittaista solupuutosta ja runsaasti vanhaa 
verihyytymää (tyyppi C), ja 2:ssa AA:n seinämä oli äärimmäisen ohut 
(tyyppi D). Uudisverisuonitusta (CD34+) oli 28:ssa (78%) näytteistä, 
eniten tyypin C seinämissä. 
Jokainen tutkittu AA sisälsi rasvaa. Veressä kolesterolia 
kuljettavien lipoproteiinien HDL ja LDL (high- ja low-density 
lipoprotein) osasia, apolipoproteiineja A-I (HDL) ja B-100 (LDL), 
oli kertynyt kaikkiin AA:n seinämiin; laaja kertyminen liittyi AA-
seinämän rappeumaan ja tulehdukseen. Rasvalla voidaankin olettaa 
olevan tulehdusta lisäävä vaikutus AA:n seinämässä. Osa AA:n 
tulehdussoluista (CD68+ ja CD163+ makrofagit) oli täynnä rasvaa, 
viitaten solujen pyrkimykseen poistaa rasvaa seinämästä syömällä 
sitä. Rasvaa oli joutunut myös seinämän sileälihassolujen (aSMA+) 
sisään. Normaalisti rasva poistuu valtimon seinämän soluista 
solukalvon tietyn porttiproteiinin (ABCA-1) ja HDL-kuljetuksen 
avulla. Vaikka näitä rasvan poistoon tarvittavia tekijöitä oli AA:n 
seinämässä runsaasti, solujen syömä rasva (adipofiliini+) näytti 
loppusijoittuneen solunulkoiseen tilaan. Ilmiö viittaa rasvaa 
sisältäneiden solujen kuolemaan ja rasvan vapautumiseen solun 
hajotessa. Koska tällainen rasvakertymä liittyi vahvasti AA:n 
seinämän rappeutumiseen ja puhkeamiseen, oletettavasti rasva 
aiheuttaa AA:ssa solukuolemaa ja heikentää seinämää, lisäten sen 
puhkeamisriskiä.
Rasvan lisäksi AA-seinämissä todettiin runsaasti punasoluperäistä 
jätettä. Punasolun solukalvoja (glykoforiini A+) oli laajalti kertyneenä 
iältään vanhoissa seinämän verihyytymissä sekä rappeutuneissa ja 
puhjenneissa AA:n seinämissä. Huomattavaa oli punasolujätteen 
runsas määrä myös vuotamattomissa AA:n seinämissä. Näin ollen 
punasoluja kertyy AA:n seinämään jo ennen sen puhkeamista, 
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millä voi olla hiljattaista AA:aa rappeuttavaa vaikutusta. Seinämään 
kertynyt punasolu vapauttaa hajotessaan solukalvojensa kolesterolia 
ja sisältämäänsä hemoglobiinia, jossa on voimakkaan hapettavaa 
rautaa. Punasolujen kertyminen liittyikin AA:n seinämässä 
hapettuneen rasvan kertymiseen sekä tulehdukseen, mikä tukee 
käsitystä punasolujen hajoamistuotteiden haitallisesta vaikutuksesta. 
Hemoglobiinia syöviä makrofageja (CD163+) esiintyi AA:ssa erityisen 
paljon. Mielenkiintoinen yksityiskohta oli makrofagien tuottaman 
hemoglobiinin hajoamistutteen, hemosideriinin kertyminen 
seinämän uudisverisuonten ympärille, viitaten seinämänsisäisiin 
mikroverenvuotoihin uudisverisuonten tihkumseen seurauksena.
Punasolujätteen kertyminen liittyi myös signaalimuutoksiin 
AA:n seinämästä kuvatuissa magneettikuvissa, joissa hemosideriinin 
kertyminen liittyi tummaan kontrastiin ja glykoforiini A:n 
kertyminen liittyi kirkkaaseen kontrastiin. Näin ollen nämä AA:n 
rappeutumiseen liittyvät muutokset voisivat olla kuvannettavissa 
magneetilla myös potilailta. Vaikka löydös on lupaava, vaatii se 
vielä tarkempia tutkimuksia, sillä nyt tutkitussa pienessä, pienien 
aneurysmien sarjassa todettu yhteys jäi tilastollisen vertailun tasolle. 
AA:n sisäisten verenvirtausolosuhteiden mallinnukset osoittivat, 
että AA:n seinämää kuluttava verenvirtaus liittyy lisääntyneeseen 
tulehdukseen (CD45+ solujen runsaus) seinämässä sekä seinämän 
rakenteelliseen rappeutumiseen. Näin ollen myös virtausmallit 
voisivat tulevaisuudessa olla avuksi korkean vuotoriskin AA:ien 
tunnistamisessa. 
Johtopäätökset
AA:n seinämässä on paljon ateroskleroosia muistuttavia 
rappeutumismuutoksia, kuten rasvan ja punasolujen sekä näiden 
hajoamistuotteiden kertymistä. Todennäköisesti näiden jätteiden 
kertyminen AA:n seinämään aiheuttaa seinämässä tulehdusta, 
hapettumista ja edelleen seinämän heikkenemistä, lisäten AA:n 
puhkeamisriskiä. Tutkimuksessa tarkennettiin tämänhetkistä 
käsitystä AA-seinämän tautitilasta ja sen mekanismeista; oletettujen 
patologisten mekanismien varmentamiseksi tarvitaan tulevaisuudessa 
kokeellisia malleja. Uutta tietoa voidaan hyödyntää AA:n puhkeamista 
ehkäisevien lääkkeellisten hoitomuotojen kehittelyssä sekä 
korkeariskisten AA-seinämien tunnistamisessa potilailta.
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1. Introduction
Subarachnoid hemorrhage (SAH) is a sudden manifestation 
of the often fatal (30-40%) intracranial bleeding that may occur 
without warning in anyone afflicted with an intracranial aneurysm 
(IA). In SAH, circulating blood breaks through the intracranial artery 
wall into the subarachnoidal space lining the brain, leading to severe 
headache, nausea, and often loss of conciousness. Even among 
those who survive, this injurious bleeding may cause disability and 
dependence upon others for the rest of the patient’s life. Worldwide, 
approximately 2-3% carry a saccular intracranial aneurysm (IA), 
whose rupture is the origin of non-traumatic SAH (85%). IA 
prevalence is highest in the working-age and elderly population, 
other risk factors being female sex, smoking, and hypertension. The 
role of other risk factors common for cardiovascular diseases in 
general, such as diabetes and hypercholesterolemia, is unclear.
An unruptured IA is silent and rarely causes any symptoms. 
To prevent rupture, IAs can be treated by closure of the IA from 
the circulation by clipping the IA neck or filling the IA sack with a 
platinum coil. Modern neurosurgical and endovascular treatment 
techniques are, however, associated with risks for complications and 
even with a small but non-negligble risk of death. Pharmacological 
treatment for IA and SAH prevention does not yet exist. Since not all 
IAs will ever rupture even if untreated, invasive treatment should be 
targeted selectively to IAs of high risk for rupture, leaving low-risk 
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and stabile IAs untouched. However, identifying the rupture-prone 
IAs among all IAs has remained a challenge. Accomplishment of novel 
methods for diagnostics and preventive treatment requires complete 
knowledge of IA pathogenesis.
IA is a frequent disease of a large cerebral artery wall, manifested 
by a focal outpuching lesion in the bifurcation area of the artery. 
Typical IA locations in the Circle of Willis arteries are in the middle 
cerebral artery and the anterior and posterior communicating arteries. 
Some IAs may evolve from the branches of the internal carotid artery, 
ophthalmic artery, posterior inferior cerebellar artery, or the basilar 
tip. Along with its bulging, the IA lesion has undergone a dynamic 
pathological wall remodeling process under the burden of chronic 
inflammation, one that may have evolved for years or even decades. 
Although family- and genetic background may play some role in 
IA pathogenesis, IAs are mainly considered to be sporadic lesions, 
influenced mainly by lifestyle- or environment-related factors.
Similar to IA, atherosclerosis is a well-known chronic 
inflammatory disease of the arterial wall. Atherosclerosis, besides 
affecting all extracranial arteries, is present also in intracranial arteries 
which show lipid accumulation. Imbalanced function of the circulatory 
lipoproteins: high-density lipoprotein (HDL) and low-, intermediate-, 
and very low-density lipoproteins (LDL, IDL, VLDL) plays a role in 
systemic atherogenic processes. Lipid accumulation is associated 
with intraluminal injury and atherothrombotic complications of the 
arterial wall. Similar changes in the IA walls such as inflammation, 
lipid accumulation, and intraluminal thrombosis are associated with 
IA rupture. However, the role of these changes in IA wall degeneration 
and rupture remain unknown.
The IA wall ruptures when mechanical stress resulting from 
the blood pressure exceeds wall strength. Understanding the 
pathobiological mechanisms that lead to IA wall weakening and rupture 
is highly important for the development of specific imaging techiques 
and pharmacological treatment methods to prevent fatal SAH. This 
thesis deepens the knowledge of IA pathogenesis particularly from 
the perspective of atherosclerotic, inflammatory changes that may 
contribute to IA wall degeneration and rupture. Through the correlation 
of IA wall histopathology with hemodynamic flow models and MRI 
presentations of IAs, this thesis also discusses potential diagnostic tools 
which might improve detection of high-risk IAs.
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2. Review of the 
Literature
2.1 Saccular intracranial aneurysm (IA) and 
subarachnoid hemorrhage (SAH)
This section reviews the macroscopic features 
of saccular intracranial aneurysms (IAs), their 
epidemiology, clinical manifestations, and treatment.
2.1.1 Rupture of an IA causes SAH
An IA is a pathological saccular lesion of a large intracranial artery 
at the base of the brain. IAs are typically located at bifurcation sites of 
arteries of the Circle of Willis [27,248] (Figure 1), where focal weakening 
of the arterial wall causes its outpouching. A majority of unruptured IAs 
are small (<5-7 mm) [146], but their diameters may range from a few 
millimetres to several centimeters for giant IAs. Whereas an intact IA 
rarely causes its carrier any harm, rupture of an IA is devastating. 
A ruptured IA bleeds into the subarachnoidal space that surrounds 
the brain, causing a subarachnoid hemorrhage (SAH, Figure 2). An IA 
may also bleed into brain tissue, into the ventricular system, or into 
the subdural space of the brain [248]. Although SAH can also originate 
from head trauma or arise spontaneously without any predisposing 
aneurysmal formation, IA rupture may account for 85% of all SAH 
incidents, making it the most notable cause for SAH. 
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2.1.1.1. Other aneurysm types in the brain vasculature
This thesis focuses on the saccular pouching type of IA, 
which accounts for the majority of all aneurysms arising in large 
intracranial arteries. However, an intracranial aneurysm can also 
be of fusiform type (Figure 3). A review of 329 surgically treated 
intracranial aneurysms reported the proportion of fusiform type 
aneurysms as 5%, the rest being of saccular type [196]. There are 
also microaneurysms of saccular morphology, known as Charcot-
Bouchard aneurysms, which occur in the smallest branches of 
intracranial arteries (arterioles) in proximity to the basal ganglia 
of the brain [233]. Due to their subcortical location, ruptured 
microaneurysms are a common primary cause of intracerebral 
hemorrhages, whereas IAs may cause intracerebral hemorrhages 
secondary to SAH.
2.1.2 Epidemiology of IAs and SAH
2.1.2.1. Prevalence of IAs
Unruptured IAs are common worldwide. International systematic 
reviews including imaging- and autopsy studies from 1955-2011 
estimate that in a population without specific comorbidities, 2.3 to 
3.2% (95% confidence interval, CI, 1.7-3.1 and 1.9-5.2) are IA carriers 
[209,252] (Figure 4). One-third of them may harbor multiple, i.e. 
two or more IAs. An autopsy study of 289 SAH patients found 
multiple IAs in 31% of them [51]. Epidemiological studies show 
similar proportions. A prospective study from a single medical 
center based in the USA reported in 1277 consecutive patients with 
aneurysmal SAH two or more IAs in 387 (30%) [162]. Among 114 
unselected IA carriers in eastern Finland, the prevalence of multiple 
IAs was similar, 34% [210].
2.1.2.2 Worldwide incidence of SAH
Although prevalences of IAs appear similar in the USA, China, Japan, 
and several European countries, including Finland [252], the reported 
incidence of aneurysmal SAH (referred to simply as SAH) varies among 
populations. According to large international studies, the incidence of 
SAH has been estimated as 9 to 10 cases per 100 000 population per year 
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in most European countries and in North America (9.1; 8.8-9.5), but 
significantly fewer in South and Central America (4.2; 3.1-5.7), and 
in China (2.0; 1.6-2.4). In Japan, SAH has shown exceptionally high 
rates (22.7 and 21.9-23.5) [55], and Finland has shown similarly high 
rates of SAH in the same studies: 19.7 and 18.1-21.3 [55] to 22.5 and 
20.9-24.1 [96], however, current epidemiological data have revealed 
a much lower Finnish incidence of SAH. 
2.1.2.3 Incidence of SAH in Finland
Recent Finnish studies show a SAH incidence lower than 
earlier estimated: approximately 7 to 9 cases per 100 000 per 
year [102,123]. This would account for 400 to 500 cases per year, 
significantly fewer than the earlier estimate of 1000 SAH cases 
annually in Finland. A study of 1965 hospital-admitted SAH patients 
from the catchment area of Tampere University Hospital between 
1990 and 2014 reported SAH incidence as annually 7.41 per 100 
000, without a clear trend upwards or downwards. However, in 
comparison with other hospital regions, marked regional differences 
emerged, with Jalava et al. reporting a 64% higher SAH incidence in 
eastern Finland than in the Tampere region [102]. 
One Finnish nationwide study, based on the register of the 
National Institute for Health and Welfare, found a 24% decrease 
(11.7 vs. 8.9 per 100 000) in average annual SAH incidence when 
comparing 1998-2000 and 2010-2012 [123]. The incidence of SAH 
decreased together with smoking, an important risk factor for SAH, 
which may explain in part this decrease. Of other cardiovascular 
disease risk factors, serum cholesterol and blood pressure values 
have also decreased among the Finnish population, according to 
wide surveys of risk factors performed in several geographical 
regions during 1972-2007 [249]. Still, no evidence exists of causal 
relations between the changes observed in SAH incidence and 
Finnish smoking habits or cardiovascular health.
It is notable that different studies of the incidence of SAH may 
prove controversial due to exclusion of cases in which sudden 
death occurred without confirmation of the diagnosis through an 
autopsy [121]. Of all deaths from SAH, approximately 10 to 20% are 
sudden [96,121,180]. In Finland, the autopsy rate for sudden deaths 
is high in any international comparison, which may have affected 
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earlier data showing Finland’s comparably high SAH rate on an 
international scale [121]. Results of epidemiological research may 
also vary widely between research centers due to differing study 
time-periods, as well as differences in population age, if not adjusted 
for. Thus, exact SAH incidence rates remain unknown.
2.1.2.4 Outcome of SAH
The outcome of IA rupture is catastrophic: nearly half (40-50%) 
of SAH patients die during the first month after SAH, including 
those 10 to 20% who die immediately, before receiving any medical 
attention [96,180]. Age-adjusted fatality rates of SAH also show 
regional dependency. Risk of death after SAH has been two-fold 
higher in Eastern than in Western Europe (62% in Yugoslavia-Novi 
Sad’s population vs. 32% in Sweden-Göteborg) [96], and around 12% 
lower in Japan (27%) than on average in Europe, the USA, Australia, 
and New Zealand [180]. A large international meta-analysis shows 
also a slight 17% decrease in fatality from SAH during the period 
1973-2002, possibly explained by improved treatment strategies 
[180]. 
Patients who survive may suffer from systemic complications of 
SAH, IA rebleedings, and long-term neuropsychological disabilities 
[248]. SAH patients are typically women (63%) of working-age, 
mean age around 60 [180]. In women, SAH occurs at a later mean 
age than in men (63 vs. 55 years) [180]. The overall mean age of SAH 
patients has been increasing during recent decades [55,111]: age 52 
to 53 years in 1973 to 1992 to 62 years in 1993 to 2002, according 
to one meta-analysis [180]. Despite such an increase in mean age, 
loss of productive life-years due to disability or death from SAH is a 
burden on both individuals and society.
2.1.2.5 IA rupture risk
Not all IAs rupture. In a lifelong follow-up of a cohort of 118 
Finnish working-aged IA carriers, 34 (29%) experienced SAH [122]. 
Risk for IA rupture accumulates over time, with average annual 
rupture risk of an IA estimated as 1.6% (range 0-6.5%) in a group of 
patients with life-long follow-up [122]; as 1.1% in another Finnish 
long-term (median 21 years) follow-up cohort of 181 IAs (142 patients) 
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[111]; and 0.76% (95% CI 0.58-0.98) in a Japanese cohort of 1960 
patients during 10 years of follow-up [173]. 
IA rupture risk most likely does not, however, increase linearly 
year by year. Rather, it may stay low for a long time, until rising 
before IA rupture [208]. Interestingly, the Finnish long-term 
follow-up study revealed no IA ruptures after 25 years, suggesting 
a decrease in rupture risk over very long periods [111]. Importantly, 
rupture risk of an IA is dependent on risk-factor burden [77,122], 
which may cause a risk increase up to many-folds higher [149].
2.1.3 Clinical risk factors for IA and SAH
IAs are not congenital, as they develop during one’s lifetime 
[231]. Their etiology is complex. Multiple independent, mainly 
environmental but also some inherited factors, are involved in IA 
formation. Currently IA rupture defies prediction, but several risk 
factors elevate rupture risk. Major patient- and aneurysm-related 
risk factors are in Table 1.
2.1.3.1 Patient-related risk factors
Fortunately, the most important risk factors, such as smoking 
and hypertension, can be influenced by lifestyle choices. However, 
some patient characteristics, including family history, genetics, sex, 
and age, are non-modifiable.
Non-modifiable	risk	factors
Family history and genetic backround 
Familial and genetic background may be one risk factor for IA 
and SAH [29,213,214,252]. Having IA carriers or SAH patients in 
first-degree relatives is associated with 3- to 4-fold risk for IA in 
a large meta-analysis by Vlak et al. (prevalence ratio, PR 3.4; 95% 
CI 1.9-5.9) [252], and with 4- to 7-fold risk for SAH in series of 
146 [214] and 163 [29] SAH patients. Approximately 10% of SAH 
patients belong to families of SAH aggregation [29,214]. Familial IAs 
have been reported to rupture 6 to 7 years younger than do sporadic 
ones (median ages of SAH 46.6 vs. 53.4 years) [29], they grow large 
more often prior to rupture (>10 mm; risk ratio, RR 2.1; 1.2-3.6) 
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Table 1. Risk factors for intracranial aneurysm (IA) 
prevalence and rupture. 
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[214], they show multiplicity [214], and they favor a location in the 
middle cerebral artery [29] 2 to 3 times more often than do sporadic 
ones.
Genome-wide linkage studies analyzing whether specific DNA 
markers linked with disease genes occur in IA families have, 
however, revealed only a limited number of gene loci showing 
replication in various populations [213]. A comprehensive review 
of 10 genome-wide linkage studies identified four such loci [213], 
including perlecan- and elastin genes involved in the maintenance 
of structural components of the extracellular matrix (ECM), i.e. 
vascular-wall-supporting tissue [213]. As a limitation, definitions of 
an IA family varied in the genome-wide linkage studies reviewed: 
differences appeared in the number of affected family members (2, 3, 
or more) and in the relationship between them [213]. 
The loci detected through a linkage study, however, do not 
necessarily apply to sporadic IAs. Thus, the genetic basis for sporadic 
IAs has been studied by genotyping single nucleotide polymorphisms 
(SNPs) to mark specific disease-associated gene alleles and further 
performing genome-wide association (GWA) studies to define 
genetic markers for increased IA risk [3,241]. A meta-analysis of 
genetic association- and GWA studies identified 19 SNPs, suggesting 
the association of various genes and multiple pathophysiologic 
pathways with sporadic IA formation and rupture [3].
However, the contribution of gene variants to SAH risk appears 
relatively small. According to a large Nordic twin study of 79,644 
twin pairs identified from Finland, Sweden, and Denmark, SAH 
had occurred for 498 pairs (152 monozygotes and 346 dizygotes), 
of whom only 6 were concordant (1.2%, 5 monozygotes, 1 dizygote) 
[124]. Thus, Korja et al. concluded that environmental and lifestyle 
factors seem more significant contributors to familial SAH risk than 
is clustering of disease genes.
Female	sex	and	age
IAs are more common in women than in men at all ages (PR 1.61; 
1.02-2.54 for a population of mean age < 50; and PR 2.2; 1.3-3.6 for 
a population of mean age > 50), and the risk for developing an IA 
increases with age especially in women [252]. Systematic reviews 
report that compared to male IA carriers, female carriers also show 
greater risk for IA rupture (RR 2.1; CI 1.1-3.9) [48,209]. 
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More specifically, SAH incidence is higher in women than in 
men after age 55 (RR 1.24; CI 1.09-1.42) [55], close to the mean age 
of menopause: 52 to 53 years [235]. The preponderance of women 
has thus been hypothesized to relate to changes in female hormone 
levels. Studies investigating hormone replacement therapy in 
postmenopausal women or oral contraceptives at their fertile age 
have shown no clear change in SAH risk, although some associations 
have appeared (see the separate section).
Specific	comorbidities
A few congenital abnormalities are risk factors both for IA formation 
and for rupture. Aortic coarctation, vascular Ehlers-Danlos syndrome 
(type IV EDS), and autosomal dominant polycystic kidney disease 
(ADPKD; prevalence ratio 6.9; 3.5-14 [252]), are associated with several 
factors which contribute also to IA disease [25,231,248,252]. Secondary 
hypertension is associated with aortic coarctation and may trigger the 
onset of IA in those patients. Connective tissue disorder due to mutation 
in the type III procollagen gene COL3A1 [254] is associated with type 
IV EDS and may also contribute to IA formation through structural 
fragility of the vascular wall. Altered hemodynamic-flow sensing (SMC 
and the endothelium –derived ADPKD gene products polycystin-1 and 
-2 responsible for mechanotransduction [193]), IAs are also associated 
with other cerebrovascular malformations such as cerebral dural 
arteriovenous fistulas, potentially due to formation mechanisms related 
to altered blood flow [78,86].
Modifiable	risk	factors
Hypertension
Together with smoking, the main risk factor for IA formation and 
rupture is chronically elevated blood pressure. An eastern Finnish 
single-center study of all hospital-admitted IA cases 1995-2007 
suggested the contribution of high blood pressure to IA formation 
[147]. Lindgren et al. observed a high prevalence of hypertension in 
IA patients, as 73% of those 467 patients with unruptured IAs and 
62% of those 1053 patients with ruptured IAs used antihypertensive 
medication. Untreated hypertension was more prevalent in patients 
with ruptured IAs (29% vs. 23%) [147]. 
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IA rupture risk increased in patients with hypertension. In a 
worldwide meta-analysis of case-control- and longitudinal studies of 
3936 SAH-patients, Feigin et al. showed that hypertension elevates 
SAH risk 2- to 3-fold (RR, 2.5; 2.0-3.1) [62]. Their other study, 
focusing on the population of the Asia-Pacific region (30,6620 
participants), specified the cutpoint level of systolic blood pressure 
as 140 mmHg, above which SAH risk was markedly increased 
(hazard ratio, HR, 2.0; 95% CI, 1.5-2.7) [61]. Moreover, every 10-
mmHg increase in systolic blood pressure was associated with a SAH 
risk 31% (95% CI, 23-38%) higher [61].
Atherosclerosis and hypercholesterolemia
Atherosclerosis is a common systemic disease of the arterial 
wall, characterized by lipid accumulation, chronic inflammation, 
and gradual occlusion of arteries. IAs have been more common in 
patients with atherosclerosis than in patients without the disease 
(PR 1.7; 0.9-3.0), although not to a statistically significant level 
[252]. That large meta-analysis of unruptured IAs did not, however, 
clearly specify how atherosclerosis was defined there [252]. Since 
the diagnosis of atherosclerosis can be based on findings in several 
different examinations, such as stenoses and calcifications of 
arteries in angiography, clinical observations in surgery or autopsy, 
or typical symptoms of affected organs, assessing atherosclerosis 
in a large number of patients is not straightforward from merely a 
database. In the meta-analysis, the atherosclerotic patients showed 
a wide range, including those with a history of transient ischemic 
attack or ischemic stroke. Besides from an atherosclerotic etiology, 
ischemic strokes often also arise from cardiac embolism. However, 
these potential confounders were not reported in detail in that 
study. Based on the heterogeneity of patients with atherosclerosis, 
epidemiologic connections between atherosclerotic diseases and 
IAs are challenging by meta-analysis, and it remains unknown 
whether there are more among atherosclerosis patients with IA than 
suspected.
The main risk factor for atherosclerosis is hypercholesterolemia 
[15]. Interestingly, in a case-control study of 206 IA carriers and 
574 controls, Vlak et al. found hypercholesterolemia to be an 
independent factor reducing the risk for IA occurrence (OR 0.5; 
95% CI 0.3-0.9) [251]. According to a meta-analysis by Feigin et al., 
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hypercholesterolemia has also been consistently associated with 
decreased SAH risk (RR, 0.8; 0.6-1.2) [62]. A Japanese case-control 
study showed that 285 patients of all age-groups with unruptured 
IAs had hypercholesterolemia more often than did those 858 with 
ruptured IAs (OR 0.24-0.53; 95% CI 0.12-0.76). Interestingly, IA 
rupture risk was particularly reduced in patients under 60 with 
hypercholesterolemia (OR 0.38; 0.22-0.68) [95]. Here, the threshold 
for total cholesterol level was at 220 mg/dL, i.e. 5.7 mmol/l [95], 
whereas in the large study of the Asia-Pacific population, it was 4.5 
mmol/l for a trend of lower SAH risk at higher cholesterol levels 
(HR 0.9; 0.7-1.3) [61]. In contrast, a recent systematic review found 
that elevated total cholesterol elevated SAH risk in men [145]. The 
mechanism by which cholesterol level affects SAH risk is, indeed, 
unknown. The potential hypercholesterolemia-associated statin 
use mediating some protective effect on the artery wall has been 
discussed (see the separate section), although not defined.
Diabetes mellitus and body weight 
Diabetes mellitus (DM) has been associated with a decreased risk 
for SAH in the meta-analysis by Feigin et al. (RR 0.3; 0-2.2) [62], 
and recently in a large study of over 2 million participants, 4327 of 
them with SAH (RR 0.4, 95% CI: 0.29-0.56 [258]. Both reports left 
DM type undefined. An eastern Finnish study assessed the use of 
DMII medication in 484 IA carriers and 1058 SAH patients, finding 
no association between the prevalence of medically treated DMII 
and SAH [148]. Further, neither body weight nor body mass index 
(BMI) has shown any clear association with SAH risk, since the data 
have been inconsistent in systematic reviews [48,61,62]. However, 
vigorous physical exercise (> 3x per week) has been an independent 
risk reducer for IA (OR 0.6; 95% CI 0.3-0.9) [251], suggesting a role 
for regular exercise in IA prevention. 
Tobacco
Current smoking is an independent risk factor for IA (OR 2.9; 
95% CI 1.9-4.6) according to the case-control study by Vlak et al. 
[251]. When combined with hypertension, the effect of smoking on 
IA occurrence appears synergistic (OR 8.3; 95% CI 4.5-15.2) [251]. 
In the Finnish long-term follow-up of patients with unruptured IAs, 
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smoking raised IA rupture risk, as well, up to 2- to 3-fold (HR, 2.44; 
1.02-5.88) [111]. Similar SAH risk ratios have been demonstrable 
in the meta-analysis of case-control studies by Feigin et al. (RR 2.2; 
1.3 to 3.6) [62]. A Finnish population-based cohort of 613 young 
(<40 years) IA patients with 105 unruptured and 508 ruptured IAs 
demonstrated that smoking is a particular risk factor for SAH in 
younger individuals (hazard ratio, HR, 2.8, 95% CI 1.2-7.0) [200]. 
That study showed that even former smoking doubles risk for SAH 
when compared to never-smoking [62], suggesting that smoking 
has a long-term effect on increased SAH risk. What has not been 
established, however, is the mechanism of how smoking influences 
IA prevalence and rupture. 
The use of snus, a smokeless tobacco product of high nicotine 
content, has been investigated in one group of 120 northern-Swedish 
SAH patients [126]. Of these participants, 10.8% were active snus 
users and 77.1% previous or current smokers. Similar to findings by 
others, also in that study smoking was associated with approximately 
2.5-fold higher risk for SAH (RR, 2.63, 1.20–5.72 for men and 2.26, 
1.69–3.01 for women), whereas snus consumption did not affect 
their SAH risk (RR, 0.48, 0.17–1.30 for men and 1.30 0.33–5.18 
for women). The authors suggest that nicotine is unlikely to be 
responsible for the smoking-related increased SAH risk [126].
Alcohol
Heavy drinking is a potential risk factor for SAH. In the meta-
analysis by Feigin et al. and the Finnish follow-up study by Juvela 
et al., consumption of up to 12 doses or standard drinks (100-150 g) 
of alcohol per week was associated with up to two-fold risk for SAH 
when compared to that for non-drinkers (RR 2.1; 1.5-2.8 [62] and 
HR, 1.27; 1.05-1.53 [111]). A retrospective case-control study of 4701 
IA patients (28% with ruptured IAs) reported increased IA rupture 
risk in current drinkers (43%, OR 1.36, 1.17-1.58), a risk increase that 
did not persist in former drinkers (6.5%, OR 1.23, 0.92-1.63) [35].
Narcotics
Cocaine, amphetamins, and ecstasy have all been related to 
hypertension-associated intracerebral hemorrhages (ICH) and 
vascular malformations [163]. One British retrospective study 
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identified 13 patients using those substances prior to ICH. Ten of 
them underwent angiography, revealing six IA carriers and three 
carriers of arteriovenous malformations [163]. Other studies have 
also shown an association between cocaine and neurovascular 
complications, including ICH, ischemic stroke, and IA rupture [64]. 
Fessler et al. showed that of 77 SAH patients, those 33 using cocaine 
were younger (32.8 vs. 52.2 years) and had smaller IAs (4.9 vs. 11.0 
mm) at rupture, than did the control group of 44 non-cocaine users 
[64]. A case-control study of 312 SAH patients and 618 matched 
controls showed that 3% of SAH patients had used cocaine within 
the previous 3-day period prior to SAH, whereas none of the controls 
had done the same (OR 24.97; 95% CI 3.95-adjusted estimate not 
calculable) [28]. Cerebral vasospasm has been suggested to be 
the cause of cocaine-related SAH, through direct smoothmuscle 
constriction, catecholamine secretion, and the subsequent acute 
elevation of blood pressure [28,163]. Marijuana has also been 
reported as an independent risk factor for SAH in a US Kansas-
based nationwide study of 118.7 million people, of whom 2.1% were 
cannabis users (OR: 1.18; 1.12-1.24). The mechanism of any link 
between cannabis and aneurysmal SAH was lacking. However, 
the authors stated that the effect of cannabis could be related to 
reversible cerebral vasoconstriction syndrome (RCVS) [215].
Coffee	and	caffeine
A prospective single-center study from Tromso, Norway, reported 
that drinking more than five cups of coffee per day is associated 
with SAH (OR 3.86; 1.01-14.73) [98]. However, their 27 161 subjects 
included only 26 SAH cases, of whom 85% (vs. 59% of controls) were 
high coffee-consumers. Later, Broderick et al. also reported that such 
caffeine consumption within the previous 3 days prior to SAH was 
associated with SAH (OR 2.48; 95% CI 1.19-5.20) [28]. A possible 
mechanism for coffee consumption’s contribution to SAH lies in 
its hemodynamic effect. Caffeine causes vasoconstriction through 
antagonizing endogenous adenosine, acutely elevating blood pressure 
level (5-15 mmHg for systolic and 5-10 mmHg diastolic value) [103]. 
With its half-life of approximately 5 hours, caffeine’s effect may persist 
for several hours after consumption of coffee beverages. Habitual 
coffee drinking may thus associate with IA formation through its 
effects on vascular stress, but causalities remain unstudied. 
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A randomized trial investigating the effect of coffee consumption 
on blood-pressure values in 107 young normotensive adults showed 
that 9 week’s abstinence from coffee reduced only slightly blood 
pressure level (systolic -3.4 mmHg; 95% CI -7.1-0.3) compared to 
levels in those who consumed 4 to 6 cups per day [17]; a minor, 
non-significant depression in heart rate occurred [17]. Therefore, 
considering SAH-preventive intervention, coffee abstinence may not 
be the most effective method for reducing blood-pressure level. Nor 
was coffee consumption associated with development of coronary 
and carotid atherosclerosis in a multicenter cohort of 5115 young 
adults during 20 years follow-up [203].
Hormone replacement therapy and  
oral contraceptives in females
Risk for SAH in postmenopausal is higher than in pre-
menopausal women, according to a systematic review of 3580 
SAH patients (odds ratio, OR 1.29; 1.03-1.61) [4]. In that review 
of a population of 1671 post-menopausal women, use of hormone 
replacement therapy (HRT) associated with decreased risk for 
SAH (OR 0.86; 0.69-1.08 for current use and OR 0.74; 0.54-1.00 
for ever use) [4]. However, a large prospective study of 93 676 
postmenopausal women (44% HRT users) showed contradictory 
results: during 11 to 13 years of follow-up, SAH occurred in 114 
patients and showed higher rates in those actively using HRT than 
in those not using the therapy (0.14% vs. 0.11%, OR 1.5; 95% CI 1.0-
2.2) [199]. The potential effect of HRT on SAH risk may, according 
to these authors, be explained by estrogen-receptor-mediated pro-
inflammatory mechanisms in the vascular walls. However, they 
reached no conclusions as to the potential contribution of HRT to 
SAH risk. 
Treatment with combined oral contraceptives (OC; including 
estrogen and progestogen), has also elevated SAH risk. One meta-
analysis showed increased SAH risk in OC users (RR 1.42; 1.12-1.80), 
but the increase was not significantly dependent on estrogen dose 
(RR 1.94; 1.06-3.56 for high dose vs. RR 1.51; 1.18-1.92 for low dose) 
[108]. The more recent systematic review of SAH patients found 
that current use of OC raised (OR 1.31; 1.05-1.64) and everuse of OC 
lowered (OR 0.90; 0.75-1.09) the risk for SAH [4]. A physiological 
explanation for this also contradictory result remains, however, 
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unclear. The phases of hormonal changes in the female life-cycle, 
such as parity, menarche age, pregnancy, labor, or puerperium, have 
shown no association with SAH risk [4]. In short, how female sex 
affects IA formation and rupture, and whether the altered estrogen 
levels after menopause play a role in IA occurrence and their 
rupture-tendency, remains unknown.
2.1.3.2 Aneurysm-related risk factors
Known IA-related risk factors for IA rupture include large size 
or irregular shape, as well as tendency for growth or development 
of daughter-sacks. Additionally, some IA locations associate with 
higher IA rupture risk. Among other clinically relevant risk factors, 
particularly those possible to examine by molecular imaging 
or other methods, are hemodynamic stress, macrophages, and 
myeloperoxidase (MPO) expression manifesting high inflammation, 
and IA-wall remodeling – all are associated with IA rupture.
Macroscopic features of an IA
The International Study of Unruptured Intracranial Aneurysms 
(ISUIA) [97] assessed the outcomes of IAs, showing that IA rupture risk 
is higher for larger (>10 mm) than smaller IAs. In a prospective 10-year 
follow-up cohort of 2252 Japanese IAs, ones larger than 5 mm were 
associated with a significant increase in rupture risk (hazard ratio 12.24, 
95% CI 7.15-20.93 [173]). A meta-analysis showed that larger size is also 
a risk factor for IA growth, which increases in larger IAs; RR for >5 mm 
IAs being 2.56 (95% CI 1.93-3.39), and for >10 mm IAs 5.38 (95% CI 
3.76-7.70), when compared to 4 mm IAs [16]. Accordingly, the growth 
rate of an IA is associated with its rupture risk. In a Finnish series of 
181 IAs (142 patients), IA diameter over 7 mm increased risk for SAH 
during decades of follow-up (HR, 2.60; 1.13-5.98) [110]. However, a 
significant proportion of IAs rupture at under 7 mm [146], so size alone 
is insufficient for detection of rupture-prone IAs that require treatment.
Irregularly shaped IA morphology and elongated IAs with high 
aspect ratios (fundus length: neck diameter) are at higher risk for 
rupture than are wider IAs, according to a recent systematic review 
(OR 4.8 95% CI 2.7-8.7) [118]. A Finnish single-center registry-based 
study of 5814 IAs (48% ruptured) in 4074 patients also noted that 
the irregular or multilobular shape of an IA associates strongly with 
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rupture, irrespective of IA size (OR 7.1 95% CI 6.0-8.3), and such IAs 
should be considered as high-risk, even in patients without other risk 
factors for rupture [146].
Location in the posterior cerebral circulation, such as in the basilar 
artery, vertebrobasilar, or posterior cerebral artery (PCA) or posterior 
communicating artery (PcomA), has, in a multi-center study, been 
another independent predictor of rupture [97], whereas in the Finnish 
population, IA in the anterior communicating artery (AcomA) has been 
an independent risk factor for SAH (HR, 3.73; 1.23-11.36) [111]. A recent 
United Kingdom (UK) -based multicenter case-control study of 2334 
IA-patients (74% with ruptured IAs) showed the predominance of both 
anterior (ACA or AcomA; OR 3.21, 2.34-4.40) and posterior (PcomA or 
other; 3.92, 2.67-5.74 and 3.12, 2.08-4.70) locations in ruptured IAs, 
over location in the middle cerebral artery (MCA) [92]. 
2.1.4 Diagnostics of IA and SAH
Unruptured IAs are mostly asymptomatic and not commonly 
screened. Thus, their detection is mainly incidental. If located 
near cranial nerves, an IA may sometimes cause palsies by nerve 
compression. However, any warnings preceeding rupture are 
rare [27]. SAH due to rupture of an IA is an emergency condition, 
manifested by typical symptoms (see Figure 5).
2.1.4.1 Imaging of IA and SAH
Routine	examinations
Non-invasive angiography identifies an IA. The imaging can 
be performed by contrast-enhanced computed tomography (CT) 
or magnetic resonance imaging (MRI) or invasively with catheter 
angiography. Since angiography can specify the size, morphology, 
and location of an IA, it is required for planning operative treatment. 
To identify SAH, non-invasive, non-contrast CT-scanning of the 
brain is the primary method to detect the acute bleeding [27,248]. 
CT is sensitive for SAH within 6 hours from onset of symptoms [22]. 
Signs of older bleeding can be detectable from cerebrospinal fluid 
examination via lumbar puncture [27], which should be performed 
in CT-negative patients with symptoms strongly suggesting SAH.
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Experimental	and	molecular	imaging
Simulation of hemodynamics within the IA lumen can be 
reconstructed from three-dimensional rotational CT and MR-
angiography (MRA) images providing further information as to 
flow conditions in the IA. Computational fluid dynamic (CFD) 
simulations for 210 IAs showed that ruptured aneurysms are 
associated with concentrated inflows, concentrated wall-shear stress 
distributions, high maximal wall-shear stress, and small viscous 
dissipation ratios [177]. It is likely that altered hemodynamic forces 
and increased wall-shear stress play roles in the pathogenesis of an 
IA, probably similar to that in atherosclerotic arteries [221].
Contrast-enhanced MRI can serve for molecular imaging of the 
IA wall structure and inflammation [20]. Ferumoxytol- or other 
ultrasmall superparamagnetic iron oxide nanoparticles (USPIOs) 
may be able to act as a marker of IA wall instability, due to their 
potential uptake by macrophages of the wall [84,264]. Gadolinium 
is another contrast material which can visualize inflammation 
in the vascular wall [34]. Gounis et al. have demonstrated in an 
experimental rabbit elastase-aneurysm model that enhanced 
gadolinium (di-5-hydroxytryptamide of gadopentate dimeglumine) 
can serve as a specific biomarker for myeloperoxidase [75], a 
neutrophil- or macrophage-derived enzyme present also in human 
IAs [76]. 
MRI can detect histopathological changes in the IA wall even 
without any use of contrast material. Honkanen et al. demonstrated 
that Perl’s-positive iron visualized in 4.7 T ex vivo MRI-scannings 
of three giant IAs [91]. Hence, iron may prove a promising marker 
of IA pathogenesis. A hybrid of opposite-contrast 3T MRA has been 
introduced to detect atherosclerotic plaques with high sensitivity 
(88%) and specificity (100%) in a small series (n=16) of unruptured 
IAs [156]. Collectively, these imaging methods allow a closer 
evaluation of the IA wall and may serve as a potential tool predicting 
risk for IA rupture in the future.
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2.1.5 Treatment Options for IA
IAs are currently managed via operative occlusion of the IA fundus, 
or are followed up. To date, pharmacological preventive methods have 
not yet been taken into wide clinical use. However, aspirin, a widely 
known standard treatment for prevention of atherothrombotic incidents 
in patients with atherosclerotic diseases, seems to be potentially 
protective also in IAs.
2.1.5.1 Operative procedures
To prevent the rupture of an intact IA or after rupture to prevent further 
bleeding, the main goal of operative treatment is the IA’s permanent 
occlusion. Methods for isolating an IA from the circulation are clip ligation 
of the IA neck by open neurosurgery (clipping), endovascular occlusion of 
the IA sack by filling it with coils (coiling), or placement of a flow-reducing 
stent (a flow diverter) over the IA neck [149] (Figure 6). After any such 
treatment, the IA becomes thrombosed, with the neck-area endothelialized.
However, both open and endovascular techniques are associated 
with significant risks [168]. Surgical clipping of unruptured IAs has been 
estimated to associate with 5 to 7% morbidity and 1 to 2% mortality [127]. 
The International Subarachnoid Aneurysm Trial (ISAT) suggests that 
coiling is associated with lower risk of disability or death by one year, 
whereas clipping appeared a more permanent treatment in the long term 
[168,169]. Since not all IAs rupture during a patient’s lifetime, what is still 
under discussion is whether and whose incidental IAs require a surgical or 
endovascular approach, and by which treatment method [25,149].
2.1.5.2 Potential pharmacotherapy
Aspirin, an inhibitor of platelet function and inflammatory 
response through acetylation of cyclo-oxygenase (COX) [33], has 
been protective against IA rupture. For a conservatively managed 
subgroup from the ISUIA cohort of 1,691 patients [97], frequent 
aspirin users showed a lower IA rupture risk than did non-users 
(OR 0.4, 0.18-0.87) [85]. Similarly, a UK-based case-control study 
of 2,334 IA patients (74% with ruptured IAs) revealed a lower SAH 
risk (OR 0.22, 0.17-0.28) [92]. In one mouse model of an aneurysm, 
aspirin reduced aneurysm formation and rupture, whereas selective 
inhibition of COX-1 did not [228]. Thus, the potential beneficial 
i ure . i al an  en as la  ea en  
i ns  is la in  an   e 
i la i n in l e  a la in  a li   l se 
e  ne k ia ani   llin  e  
sa k i  ensel  a kin  ils ia e al 
a e    la e en   an in al inal 
s en  a  i e e   i e  l    
ass e  sa k
46
effect of aspirin in the IA wall may be mediated through its COX-2 
inhibition. Despite the effect of primary thrombosis inhibition by 
aspirin, its use did not associate with poor outcome in 274 SAH 
patients [79], suggesting that aspirin would not cause additional 
complications if the IA ruptures. Clinical trials to investigate whether 
aspirin therapy could reduce IA formation and rupture, especially 
in patients carrying small (3-7 mm) unruptured IAs, are currently 
underway.
Statins, hydroxymethylglutaryl-coenzyme A (HMG-CoA) 
reductase inhibitors, are in wide use to lower cholesterol levels. 
Their effect on the aneurysmal artery wall in ex vivo cultured, 
unruptured human AAAs show that statin treatment is beneficial 
by inhibiting proinflammatory effects of the nuclear factor-kappa 
B (NF-κB) signaling pathway, matrix metalloproteinases (MMPs) 
2 and 9, and monocyte chemotactic protein-1 (MCP-1) [260]. 
The anti-inflammatory effect of statins was independent of their 
lipid-lowering effects in an elastase-induced rat AAA model, in 
which atorvastatin also increased collagen and elastin synthesis in 
the aneurysm wall [223]. Similarly, in experimental rat cerebral 
aneurysms, simvastatin [8] and pitavastatin [11] suppressed 
inflammation and inhibited medial thinning and enlargement of the 
aneurysm wall. In an epidemiological study statin was associated 
with lower IA rupture risk (OR 0.40, 0.33-0.50) [92]. 
It therefore appears that the anti-inflammatory functions of 
statins could prove useful in treatment of IAs. However, a large 
retrospective cohort of 28,931 carriers of unruptured IAs showed 
no difference in their risk for SAH in a mean follow-up time of 
30 months, when comparing risk in current or recent statin users 
(41.3%) to the risk in those without treatment [19]. Whether statins 
have any beneficial effect on human IA in vivo, and whether their 
potential effect would be mediated via their anti-inflammatory or 
cholesterol-lowering functions, thus remains unknown.
2.1.6 Prediction of IA rupture
No comprehensive methods for IA rupture prediction exist. 
PHASES scoring is one tool to evaluate an individual’s SAH risk 
based on selected risk factors for IA rupture: Population, i.e. ethnic 
background, Hypertension, Age, Size, Earlier SAH, and Site [77]. 
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The total score corresponds to annual IA-rupture risk (range 0.4-
17.8 [77]). Notably, the PHASES score does not include the effect 
of smoking; moreover, hypertension in the score refers only to 
hypertension history, not taking into account any blood-pressure 
interventions after IA detection. Currently, risk for IA rupture 
is estimated individually for each IA patient, based on the risk 
characteristics of both the IA and the patient.
2.1.7 Challenges in IA Management
Rupture of an IA is unpredictable and often fatal, and the 
operative methods for preventing of the IA rupture are invasive and 
risky. Many IAs would remain silent for a lifetime [122], even if left 
alone. The largest multicenter study of unruptured IAs, the ISUIA, 
suggests that risk from surgery is greater than rupture risk for small, 
less than 10 mm, IAs during 7.5 years of follow-up [97]. However, 
that time-frame is relatively short when applied to the average 
working-aged population of IA carriers, whose life expectancy is 
many-fold longer. Importantly, reliable estimates of IA rupture risk 
among differing populations are few [121].
Evaluation of each patient’s risk for IA rupture is based on 
individual risk factors. Risk-factor scores are based on generally 
known risk factors for IA rupture but do not necessarily reveal the 
IA rupture risk for an individual patient. Routine imaging methods 
provide data on the IA at macroscopic level, such as its size and 
shape, as well as its tendency for growth if followed up. However, 
even those IAs showing no risk features in macroscopic evaluation 
may rupture, if the IA wall is weak. 
More detailed data on fragility of the IA wall requires more 
specific imaging methods. Despite not yet being in routine clinical 
use, methods such as contrast-enhanced MRI and dynamic flow 
simulations are promising options for prediction of IA rupture 
risk. However, to interpret data provided by molecular- and flow-
model -based imaging methods, more knowledge is needed of the 
mechanisms in the IA wall prior to wall rupture. Development of 
more specific imaging methods requires complete understanding of 
the pathogenesis of IA formation and rupture, essential also in the 
development of pharmacological options for preventing rupture.
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2.2 Saccular intracranial aneurysm 
pathogenesis
2.2.1 Normal artery wall structure
The normal arterial wall structure is divided into three histological 
layers: tunica intima, media, and adventitia. The innermost of the 
layers, the intima, represents the inner surface of the vessel wall 
from the basal lamina connecting the luminal endothelium to the 
hypocellular space between the endothelium and the media. 
The intima contains negatively charged glycosaminoglycans 
secreted by the mural cells of the media. The middle layer, the media, 
consists mainly of smooth muscle cells (SMCs) responsible for the 
tensile strength of the artery wall and its capacity to adapt to blood-
pressure changes, regulating vessel diameter through the cardiac-
pulse cycle [154]. The outermost layer, the adventitia, is mainly of 
loose connective tissue collagen (type I and III) and elastin fibers 
and fibroblasts, which produce the components of the extracellular 
matrix (ECM) together with the mural SMCs. In arteries larger than 
the smallest capillaries, the adventitia contains vasa vasori, i.e. small 
vessels that supply oxygen to the cells of the media and the adventitia. 
To support the media, elastic fibers are packed into two dense 
surrounding layers in peripheral artery walls (internal and external 
elastic lamina, IEL and EEL) [154,204,240]. In intracranial arteries, 
the EEL is only weakly developed compared to the IEL. The IEL 
regulates the diffusion of substances between the intima and media 
through its fenestrations, the size and density of which tend to 
increase with age. Degenerative changes in the IEL may also play 
a role in atherosclerotic diseases [194,219]. In intracranial artery 
bifurcation regions, the medial layer also has a narrow gap (medial 
raphe), which lacks smooth muscle cells (SMCs) and is filled instead 
with strong collagen fibers [65]. This anatomical defect may, however, 
not contribute to IA formation [229]. Figure 7 shows a schematic 
illustration of the layered structure of healthy intra- and extracranial 
artery walls. 
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2.2.2 Remodeling of and degeneration of the IA wall 
An IA wall differs from a healthy intracranial artery wall, since 
it lacks the original defined arterial wall layers and the supporting 
IEL. Nevertheless, the remodeled structure of the IA wall does 
include intimal, medial, and adventitial portions, resembling the 
original layer-like structure. Altered hemodynamic forces and the 
subsequent increased shear stress in the lumen of an IA sack are likely 
contributors and triggers of such remodeling changes within the IA 
wall [70,71,116,230,231] (Figure 8).
2.2.2.1 Structural changes towards a rupture-prone IA wall
Along with the microscopic process of IA wall remodeling, 
macroscopic dilatation of the IA wall occurs. IA walls are classified 
according to histological morphology and signs of structural remodeling 
(Figure 9) [70,116]. 
Loss of functional endothelium, also known as endothelial erosion, 
is one of the main events triggering further aneurysm wall degeneration 
and inflammation in an experimental rat model [104], and possibly also 
in human IAs [70,71,242]. The site of endothelial erosion is instantly 
covered by a thrombocyte monolayer, fibrin, and erythrocytes. The 
thrombosis may develop further and become a thick layer of thrombus, 
which may organize and become an integral part of the IA wall by 
means of SCM or myofibroblast migration into the thrombus. An 
organized thrombus is a common finding in an IA [70,71]. 
The medial layer may rearrange itself through SMC proliferation, 
similarly to myointimal hyperplasia, and by SMC death through 
apoptosis or necrosis [70,116,133,217,230,245]. SMCs play a 
dynamic role in adaptation to hemodynamic and other stresses of the 
vascular wall [205], and their loss is deleterious for an IA [68]. In an 
experimental rat model of peripheral artery aneurysm, loss of SMCs 
led to aneurysm growth and rupture [153]. Importantly, SMC loss 
in patients has associated strongly with IA rupture [68,70,116,245]. 
Active remodeling of the ECM is also a central process occurring 
in the IA wall [32], with proteolytic activity by MMPs and serine 
proteases likely contributing to degradation of ECM components 
such as collagen, gelatin, and glycoproteins [32]. Disintegration of 
the ECM not only causes weakening of the tensile strength of the 
arterial wall but also induces apoptotic death of mural cells, whose 
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survival is physiologically dependent on connections to surrounding 
tissues [232]. 
The IA wall shows expression of various growth factors and 
their receptors [69,132], of which transforming growth factor (TGF)
β-R2 and vascular endothelial growth factor (VEGF)-R1 associate 
with IA wall remodeling and rupture [69]. A gene expression 
profile of 11 ruptured IAs compared to that of 8 unruptured IAs has 
revealed a significant upregulation of signaling pathways responsing 
to processes such as turbulent blood flow, vascular remodeling, 
extracellular matrix degradation, oxidative stress, chemotaxis, and 
leukocyte migration, [132]. Upregulation of hypoxia-inducible factor-
1A (HIF-1A) was detectable in ruptured IAs, suggesting occurrence of 
hypoxic conditions in the IA wall [132]. 
To prevent tissue hypoxia and necrosis in a variety of 
physiological conditions, including tissue repair and reproduction, 
wound healing, and inflammation, endothelial cells undergo 
neovascularization [170]. Typically, neovascularization is initiated 
via branching of adventitial vasa vasori. Recently, neovascularization 
has been demonstrated in the IA wall in association with 
inflammatory cell infiltration [90]. Chronic inflammation is present 
in IA lesions both pre- and post rupture, as reviewed by Tulamo et al. 
[242]). IAs show also marked lipid accumulation [72,125,244].
2.2.3 Inflammation in the IA wall
Inflammation is a defensive response of an organism to resist 
injurious stimuli [216]. The destructive effect of inflammation 
is thus targeted at the offending stimulus, such as infection, 
irritation, or injury. However, the defensive response also 
affects the tissue itself, causing the classical symptoms of an 
inflammatory reaction: “calor, dolor, rubor, tumor, et functio 
laesa,” heat, pain, redness, swelling, and loss of normal function 
[216]. Because of its essential task, inflammation occurs in a 
variety of human diseases: cancer, infections, and autoimmune 
and cardiovascular diseases.
Importantly, chronic inflammation plays a role in IA 
pathogenesis, where it associates with IA wall remodeling and 
rupture [47,70-72,116,133,243-245]. The IA wall is subjected 
to multiple stresses which likely trigger and regulate the 
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inflammatory response in the IA wall. Firm causal relations 
between IA-wall inflammation and potential proinflammatory 
stimuli such as hemodynamic stress, exposure to toxic 
compounds, accumulation of infectious particles, or atherogenic 
excess material in the wall are, however, not well known. 
Inflammatory cells present in the IA wall and potential 
proinflammatory roles of different stimuli are reviewed in the 
following sections.
In general, the immune response is divided into a less-
specific innate immunity and a highly specific adaptive 
immunity. The innate immune response is mainly mediated 
by neutrophils, macrophages, and dendritic cells, which detect 
foreign material in their environment with pattern recognition 
receptors [101]. Adaptive immunity is mediated by a range of T 
and B lymphocyte subtypes, which are activated specifically by 
the stimulus presented by innate immune cells in their human 
leukocyte antigen (HLA) receptors. Figure 10 summarizes the 
basic features of inflammatory cells operating in arterial walls. 
2.2.3.1 Inflammatory cells in the IA wall
Regardless of rupture status, inflammatory cells are present in 
the IA wall [51,71,242]. Polymorphonuclear leukocytes have been 
detectable in the IA wall [51,71,242], indicating the presence of 
neutrophils, an important population of innate immunity. Their 
extent in IAs is, however, unknown. 
The IA wall also shows infiltration of small rounded cells, 
reflecting the presence of lymphocytes: both T (CD3+ and CD45RO+) 
and B (CD20+) lymphocytes [47,70,71,245], suggesting the role of 
adaptive immunity in IA-wall pathobiology. Immunohistochemistry 
findings of immunoglobulins G and M in the IA wall [47,244] 
suggest involvement of B-cell activation in IA-wall pathogenesis. 
Natural killer T (NKT) cells have also been detectable in IAs [125]. 
Accumulation of T lymphocytes is most extensive in degenerated 
and ruptured IAs [70,245]. The potential role of these wide range 
T lymphocyte subsets for human IA formation and rupture has, 
however, remained unknown. One hemodynamically induced 
aneurysm model in rats showed no progressive response to the 
presence of or inhibition of CD3+ T lymphocytes, suggesting that 
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their function was nonessential in that aneurysm model [167]. 
Several series of unruptured and ruptured IAs have demonstrated 
that the extensive presence of macrophages associates with IA-wall 
rupture [70,71,116]. The CD163+ subtype appears the major leukocyte 
type in the IA wall, suggesting its significant role in the IA-wall 
pathogenesis [70]. CD68+ macrophages are numerous as well in the 
IA wall, and thus are likely to play a role [47,71,116,245]. Notably, 
since macrophages appear in ruptured IA walls resected shortly after 
rupture, as well as in unruptured IAs, they seem to accumulate in IA 
walls even before rupture [70]. Their role in the IA wall has remained 
unestablished, however.
Mast cells (MCs) are proinflammatory and atherogenic cells 
in atherosclerotic artery walls [129] and in AAAs [160]. They also 
have been detectable in intracranial arteries close to ruptured IAs 
[59], and more recently also in IA walls [83]. In an experimental rat 
model, MCs contributed to formation and wall degeneration of an 
induced cerebral aneurysm [99].
2.2.3.2 Mediators of inflammation
Pro-inflammatory signaling in hemodynamic changes
NF-κB, a transcriptional factor expressed in human IAs [132], 
is located especially in the intima [13]. In cultured endothelial cells, 
wall-shear stress causes NF-κB activation through degradation 
of an associated IκB-component and translocation of normally 
cytoplasmic NF-κB into the nucleus [21]. NF-κB cause increased 
macrophage infiltration into the wall of an induced aneurysm rat 
model, potentially through induction of vascular cell adhesion 
molecule-1 (VCAM-1) –mediated leukocyte extravasation, and 
through MCP-1 expression [13], which attracts circulating monocytes 
to infiltrate into the tissue [115,182]. 
 E26 Transformation-specific Sequence (Ets-1) is another 
transcriptional factor expressed in endothelial cells and arterial 
SMCs that can regulate arterial inflammation through MCP-1 [182]. 
Ets-1-mediated MCP-1 expression in SMCs also contributed to IA 
formation in an experimental rat model [9,10]. In ruptured human 
IAs, gene transcription factor analysis has revealed upregulation of 
both NF-κB- and Ets-signaling pathways [132]. 
According to one hypothesis regarding its mechanism, high fluid 
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shear stress could amplify the NF-κB- and ETS-signaling pathways, 
and also the prostaglandin E2 receptor (EP2)-COX-2-pathway 
described in cultured human endothelial cells [14]. The human IA 
wall also expresses COX-2, the expression of which is increased in 
ruptured walls [228]. In the rodent aneurysm model of Aoki et al., 
inhibition of EP2 or of COX2 suppressed NF-κB-mediated chronic 
inflammation. The authors therefore suggested the maintenance of 
chronic inflammation in the IA wall through these hemodynamic 
stress-induced inflammatory pathways [12,14]. 
Triggers of cell apoptosis
Apoptosis is programmed cell death, characterized by 
morphological changes in the dying cell and activation of caspases, 
cysteine protease enzymes, through their cleavage [232]. The 
trigger for apoptosis can originate either from inside the cell via 
a mitochondrial (intrinsic) signaling pathway, or outside the cell 
via the first apoptosis-signal (Fas) receptor-mediated (extrinsic) 
pathway. Expression of both Fas and its activating cytokine, TNF-α, 
have been increased in a series of 10 ruptured human IA walls 
compared to control cerebral artery walls [105]. This suggested a 
role for the extrinsic TNF-α-Fas-pathway in the induction of IA 
wall inflammation and apoptosis [105]. Another study reported, 
however, the complete absence of cleaved caspase-8, the extrinsically 
activated type of caspase, in protein lysates of 15 unruptured and 
17 ruptured IAs [133]; instead, they found caspase-9 in 5 ruptured 
IA walls, indicating an intrisically activated apoptosis pathway. 
They suggest that caspase-9 activation originates from disturbed 
cellular homeostasis resulting from oxidative stress and the cytotoxic 
extracellular environment of the arterial wall [133].
Factors	mediating	oxidative	stress
MPO is a neutrophil- and macrophage-derived enzyme that 
catalyzes oxidation of lipids, proteins, and lipoproteins [53,114,136]. 
Oxidation or any other type of modification of lipids predisposes 
their accumulation into tissues and their phagocytosis [43]. Due 
to its strong oxidative capacity, MPO is atherogenic in the arterial 
wall. MPO also occurs in the IA wall, and is associated with greater 
risk of rupture [76]. In an experimental mouse model of a cerebral 
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aneurysm, MPO contributed to aneurysm formation and rupture 
[46]. 
Heme oxygenase-1 (HO-1) is an anti-oxidating enzyme 
that degrades erythrocytes’ oxidative hemoglobin to less-toxic 
metabolites [220]. Polymorphism of the HO-1 gene may play a 
role in IA formation [171]. A genotype-analysis of 39 IA patients 
and 230 age-matched controls revealed long dinucleotide repeats 
in HO-1 gene-promoter regions more likely in the IA patients than 
in controls, suggesting downregulation of the protective HO-1 in 
IAs [171]. Laaksamo et al. demonstrated by immunostaining the 
presence of HO-1 in the IA wall, showing that HO-1 expression is 
associated with wall degeneration and rupture [133].
Complement system activation 
Complement activation is a hierarchical protein cascade which 
regulates inflammation [58]. It is associated with the pathogenesis of 
atherosclerosis [183,184], and with IA-wall degeneration and rupture 
[243-245]. The membrane attack complex of the complement occurs 
widely in decellularized and degenerated areas of the IA wall and 
in lipid-accumulation areas, suggesting the role of this complement 
system with chronic IA-wall inflammatory processes. The complement 
system in the IA wall becomes activated via a classical pathway with 
alternative pathway amplification. The classical pathway activation 
can be induced by C-reactive protein (CRP), immunoglobulins (Ig), 
and oxidized lipid, all detected also in IAs [244].
Infectious material in the IA wall
Chronic periodontitis is associated with cardiovascular diseases 
[2,52] and with AAAs [57], in which dental bacteria initiate the 
proteolytic and proinflammatory activity of neutrophils. Recently, 
studies have focused on potentially infectious material in the IA wall, 
with Pyysalo et al. finding evidence of dental bacterial DNA in 21 of 36 
(58%) ruptured perioperatively-obtained IA specimens [197]. However, 
evaluation of unruptured IAs has revealed no significant difference in 
the distribution of bacterial DNA (unruptured: 20/28, 71%; ruptured: 
29/42, 69%) [198]. The role of bacterial DNA in the IA pathobiology 
remains open. 
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2.2.4 Atherogenesis of the IA wall
In degenerated IA walls, a very common finding is lipid 
accumulation [72,125,244], occurring independently of plasma 
lipid levels [72]. It seems likely that endothelial erosion facilitates 
the entry of lipid particles into the IA wall [71,72]. Circulating 
lipid-transporter-particle apolipoprotein-B (apoB-100 [7]) 
occurs in the IA wall [72], reflecting transportation of lipids 
to the IA wall. Hydroxynonenal (HNE) and adipophilin in the 
IA wall [72,244] indicate the presence of oxidized lipids [188] 
and intracellular lipid accumulation there [87], suggesting 
lipid phagocytosis occurring in the IA wall. Kosierkiewicz et 
al. reported in atherosclerotic IAs also major histocompability 
complex type II (MHC-II, i.e. human leukocyte antigen-DR, 
HLA-DR) expression in macrophages and SMCs [125], reflecting 
their antigen-presenting function, potentially subsequent to 
lipid phagocytosis. These findings of lipid accumulation in 
IA walls suggest atherogenic mechanisms similar to those in 
atherosclerotic arterial wall pathologies.
2.3 Atherosclerosis of the arterial wall
Atherosclerosis is a chronic inflammatory disease of the 
arterial wall in which accumulation of lipids causes thickening, 
calcification, and degeneration of that wall [151]. The nature of 
this disease is systemic, but the most clinically relevant anatomical 
locations for atherosclerosis are coronary arteries, arteries 
of the lower limbs, and internal carotid artery bifurcations. 
Atherosclerosis commonly also affects intracranial arteries 
[89,265]. 
Classically, an atherosclerotic lesion causes stenosis in the 
arterial lumen, resulting in abnormal hemodynamic conditions at 
the lesion. Disturbed perfusion of the target organ may eventually 
cause symptoms including ischemic pain or dysfunction of the 
organ due to tissue hypoxia. Atherosclerotic disease may slowly 
advance until the affected arterial lumen becomes totally occluded. 
In such slowly progressing cases, a network of collateral vessels 
develops to supply blood to the target tissue suffering from chronic 
ischemia. Sudden intraluminal rupture of a fragile atherosclerotic 
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lesion of a coronary artery then causes thromboembolic acute 
occlusion of artery and a highly fatal myocardial infarct (reviewed 
in [218]). A similar mechanism may occur in atherosclerotic lesions 
of the internal carotid or intracranial arteries, whose intraluminal 
thrombosis and occlusion results in ischemic attack on the brain, 
i.e. ischemic stroke.  
The main risk factors of atherosclerosis, including 
hyperlipidemia, hyperglycemia, aging, hypertension, and smoking, 
are in part the same as for IAs. In extracranial arteries, formation 
of an atherosclerotic lesion is characterized by accumulation of 
lipids in the intima, the innermost layer of the wall [82,128,143]. 
Lipids retained within the lesion become modified and 
phagocytozed by macrophages, causing chronic inflammation and 
contributing to arterial wall fragility (Figure 11).
2.3.1 Lipid metabolism in the arterial wall
The human body receives lipids such as cholesterol, 
phospholipids, and triglycerides either via dietary intake or via 
hepatic synthesis. Cholesterol is a physiological compound of cell 
membranes [222]. Tissues receive their essential cholesterol via 
either an endogenous or exogenous pathway; they either synthesize 
cholesterol themselves or internalize liver-derived cholesterol 
through apolipoprotein transportation. Bidirectional apolipoprotein 
traffic is responsible for systemic lipid transport in arterial walls 
[31,128,237,238]. 
2.3.1.1 Mechanisms of lipid traffic
These cholesterol-, phospholipid-, and triglyceride lipids 
shuttle in the circulation packaged within phospholipid-
monolayered lipoprotein particles which carry them into target 
tissues. Liver-originated apoB-100-containing lipoproteins 
are classified according to their protein content as very low-, 
intermediate-, and low-density lipoproteins (VLDL, IDL, and 
LDL). These particles are relatively small in size (20-30 nm) and 
are responsible for lipid traffic towards the wall. Lipoproteins 
such as chylomicrons (over 500 nm) are too large to directly 
enter the arterial wall and require further processing in the liver 
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before their lipid load can be mobilized [238]. The smallest 
of lipoproteins, apolipoprotein A-I (apoA-I)-containing high-
density lipoprotein (HDL; 7-13 nm) particles are responsible for 
lipid clearance from the wall and for carrying lipids back to the 
liver through the circulation. Depending on the phase of lipid 
clearance, apoA-I may travel also in a solitary manner, without 
any associated lipids [129,144,178,238]. 
2.3.1.2 Development of atherosclerotic plaque
An adverse shift in the balance between lipid accumulation- 
and clearance mechanisms leads to lipid-laden foam-cell 
formation and progression of an atherosclerotic lesion, i.e. 
atherosclerotic plaque, in diseased arterial walls. Thus, 
the development of atherosclerotic plaque includes lipid 
accumulation in the intima, lipid phagocytosis, incomplete lipid 
clearance, and ultimate lipid retention in the arterial wall. The 
end result, a thickened arterial wall with a necrotic lipid core and 
chronic inflammation, is characteristic of atherosclerotic plaque 
[129,144]. 
Primary lipid accumulation in the arterial wall
Lipoprotein particles can enter the intact arterial wall via 
endothelial cell transcytosis or through endothelial cell junctions 
[7,129,144,227]. Endothelial erosion or loss causes dysfunction 
of its barrier function and leads to its increased permeability 
to lipid influx to the arterial vall via endothelial cell junctions 
[7,227]. Inbalance in lipid transportation causes excess lipid 
accumulation in the arterial wall, where apoB-100-associated 
lipoproteins have the affinity to bind to the negatively charged 
proteoglycans of the ECM [225]. 
Oxidation or other modification of accumulated apoB-100-
containing lipid particles occurs in the ECM [141,192] and 
generates highly reactive fragments of oxidized fatty acids 
such as malonialdehyde, copper, or HNE, which can bind to 
apoB-100 [188,227]. Such lipid waste is cytotoxic and triggers 
inflammation. 
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Lipid phagocytosis in the arterial wall
Macrophages and SMCs in the arterial wall are activated to 
phagocytoze the retained, modified lipid particles [80]. To adapt 
to the circumstances of lipid load, SMCs may also express the pan-
macrophage receptor CD68, as demonstrated in atherosclerotic 
aortas [6]. Antibodies can opsonize the lipid particles to facilitate 
phagocytosis [259]. Clearance of accumulated extracellular lipid 
debris by inflammatory cells within atherosclerotic plaques aims at 
stabilizing the arterial wall [80,129,143]. Subsequent intracellular 
lipid accumulation turns the lipid-ingesting phagocyte into a lipid-
storing foam cell. After ingestion, apoB-100 is degraded in lysosomes 
[30]. The modified, cytotoxic lipid can, however, disturb normal 
lysosomal metabolism, leading to accumulation of apoB-100 and 
HNE in the cytoplasm of a phagocyte [106,150,237], where such a 
lipid load also disturbs other cellular functions [237]. Intracellular 
lipid droplets become covered by adipophilin [87], which has been 
demonstrated to prevent any lipid efflux from cultured macrophages 
and thus to enhance intracellular lipid accumulation in the foam 
cells of atherosclerotic plaques [135]. 
Lipid clearance in the arterial wall
To prevent any intracellular lipid overload in the tissues, the 
apoA-I- and HDL-mediated cellular lipid clearance mechanism 
transports lipids and cholesterol in reverse from the arterial wall 
back to the liver, where the excess cholesterol is excreted into the 
bile [129,144,178]. To perform lipid efflux from foam cells, the 
apoA-I lipoproteins operate via the adenosine-triphosphate-binding 
cassette A1 (ABCA1) or G1 cell-surface transporters, of which ABCA1 
can deliver intracellular cholesterol to either lipid-rich or lipid-poor 
apoA-I particles [178]. In atherosclerotic arterial walls, ABCA1 is 
expressed on foam cells either of macrophage or of SMC origin [138]. 
Failure of intracellular lipid clearance leads to foam cell death 
and extracellular accumulation of lipids. Death of foam cells causes 
adipophilin-covered lipid material to be released in the extracellular 
space, where a necrotic lipid core of an atherosclerotic plaque 
forms [41,129,141,237]. Contrary to LDL and other atherogenic 
lipoprotein particles, HDL particles are not themselves retained 
in the arterial wall [7] unless attached to apolipoprotein E (apoE), 
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which can bind to ECM proteoglycans [181]. HDL may, however, 
become dysfunctional in an inflammatory environment, especially if 
MPO and oxidative stress occur [211]. Therefore, dysfunctional lipid 
clearance mechanisms may also facilitate atherogenesis. 
2.3.2 Neovascularization and microhemorrhages in 
atherosclerosis
Neovascularization, a physiological mechanism to 
prevent tissue hypoxia [170], typically occurs in thickened 
atherosclerotic plaques. Oxygen can diffuse for approximately 
250 to 500 micrometers in the vascular wall [206], and 
cells located at a greater distance from the lumen, if 
not supplemented by vasa vasori, demand neovascular 
oxygen sources. Infiltration of inflammatory cells into the 
atherosclerotic plaque cause increased oxygen use, thus 
triggering neovascularization. Neovascularization is initiated 
from vessel-sprouting under the regulation of HIF-1 and 
vascular endothelial growth factor (VEGF). MMPs, especially 
MMP1, promote endothelial cell detachment from mural 
SMCs. Chronically upregulated neovascularization may lead to 
formation of immature neovessels [170]. Plaque neovessels also 
contribute to lipid accumulation [139], serving as an optional 
route for excess lipids to enter the wall.
Immature neovessel walls are thin and lack a connection to 
the surrounding tissue, which predisposes them to leakiness 
[224]. Leaky neovessels are a major cause of intramural 
microhemorrhages [250]. In the arterial wall, the extravascular 
erythrocytes lyse and release their cholesterol-rich cell 
membranes, thus contributing to lipid load in the arterial 
wall [120,155,250]. Erythrocyte extravasation, marked by 
glycophorin A (GPA), an erythrocyte-specific membrane 
protein [18], is associated with atherosclerotic plaque 
vulnerability in coronary [120,139] and carotid [165] artery 
lesions.
Erythrocyte lysis also liberates the iron-containing oxidative 
heme into the arterial wall (Figure 12) [155,250]. Retention 
of iron has been considered a contributor to atherosclerotic 
pathologies, due to the high oxidative potential of free iron 
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ions (Fe2+) [164,201,261]. To limit iron load in the tissue, 
synthesis of ferritin, an iron-storage protein, is upregulated by 
iron, oxidative stress, and inflammatory cytokines. Excessive 
nonbound iron is phagocytozed and stored in hemosiderin 
(FeIII, the Roman numeral referring to a bound form of iron) 
[164]. The free heme-derived iron is highly soluble and has 
a strong capacity to catalyze the formation of toxic reactive 
oxygen species (ROS) such as hydrogen peroxide (H2O2), 
hydroxyl radical (OH.-), and superoxide (O2.-). These free 
radicals may liberate more iron from hemoglobin and oxidize 
LDL, thus mediating deleterious, atherogenic effects in the 
arterial wall [155,164,165,201,261]. 
In addition to neovessel-derived erythrocyte leakage, 
thrombus-derived erythrocyte lysis has also been considered 
as a likely source of iron accumulation within the arterial 
wall [155,165]. Hemosiderin deposition, representing an 
intracellularly generated product of iron phagocytosis, has 
been detectable also in the IA wall [71,91]. 
2.4 Atherosclerosis in the IA wall – Summary
Atherosclerotic changes had already been detected in 
autopsied intracranial arteries of the Circle of Willis in 1961 
[265]. Atherosclerosis is a common finding also in IAs. 
Atherosclerotic changes in the IA wall are notable, both in 
macroscopic observation in an intraoperative setting [189] 
and in microscopic evaluation after IA resection of the IA sack 
[70,72,125,244]. Indeed, various structural changes occur both 
in atherosclerotic plaques and in IA walls. Endothelial loss, 
i.e. erosion, and the subsequent thrombosis and remodeling 
of the media are characteristic for both pathologies. Chronic 
inflammation plays a significant role in regulation and 
maintenance of these remodeling changes. Similar to the 
atherosclerotic wall, IA also accumulates lipids, which oxidize. 
Oxidative stress, hemosiderin deposition, and neovascularization 
are involved in both pathologies. There are also differences, 
because the pathological process of atherosclerosis is mainly 
focused in the intima, whereas in the IA, the entire wall becomes 
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weaker than a normal artery wall. The outcomes of the diseases 
differ accordingly: while the atherosclerotic lesion ruptures 
only partly from its luminal surface, causing acute occlusion of 
the affected artery by thrombosis or thromboembolism, the IA 
ruptures through its entire wall, causing often-fatal SAH. The 
role of atherosclerotic and other changes in the IA wall warrants 
our deeper understanding, allowing us to learn how to better 
prevent IA formation and rupture.
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3. Aims of the 
Study
The purpose of this thesis was to deepen knowledge 
of human saccular intracranial aneurysm (IA) 
pathogenesis, especially from the perspective of 
atherosclerotic	and	inflammatory	IA	wall	changes.	
Specifically,
1) Is there a role for mast cells and neovascularization in IA wall 
degenerative remodeling, as there is in atherosclerosis (I)?
2) Does lipid accumulation contribute to IA wall remodeling and 
rupture, and what are the potential mechanisms of IA wall 
lipid accumulation and lipid clearance (II)?
3) Does intraluminal hemodynamic stress play a role in IA wall 
pathogenesis (III)? 
4) What is the role for erythrocyte breakdown products in IA 
pathogenesis, and are they visualizable in small IAs with non-
contrast ex vivo MRI (IV)?
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4. Materials and 
Methods
4.1 Aneurysm samples
This study covers in total 55 (25 unruptured and 30 ruptured) 
intraoperatively collected human saccular intracranial aneurysm 
(IA) samples. All IA specimens were studied by histological 
and immunohistochemical methods, and some of them were 
also scanned with ex vivo MRI to compare the radiological and 
histological findings of the IAs. The Hospital Ethics Committee 
approved the reasearch protocol.
4.1.1 IA sample collection and processing
Collection of IA fundi took place intraoperatively after clipping 
of the 55 IA neck at the Department of Neurosurgery, Helsinki 
University Central Hospital, Finland. After resection, 44 (Figure 13) 
of the IA fundi were immediately snap-frozen for further processing, 
and 11 (Figure 14) were fixed in formalin for magnetic resonance 
imaging (MRI) ex vivo.
4.1.2 Patients and IA studies
All 55 IA samples originated from di erent patients whose 
clinical data came from their medical records (Table 2). IA-
dimension measurements were from preoperative computed 
tomography angiography (CTA) images. Table 3 speci es the use 
of IAs in the studies of the thesis. Samples 1 to 36 were the most 
extensively analyzed, being involved in Studies I, II, and IV. Of the 
36 IA patients, 11 participated also in Study III, with the supplement 
of 9 additional IAs. Finally, Study IV was supplemented by 11 IAs 
that underwent ex vivo MRI scanning after resection.
i ure 1 . ne s sa le essin  a e  
lle i n  n e ine l   s  
ese e   n i e e i e ia el  sna
en in li i  ni en  an  a e a s 
e e e  in iss e ek ak a  l en 
aan en i n  e e e lan s  an  s e  
a     is l i  e al a i n  e 
sa le l ks e e se iall  se i ne  
a   
i ure 14. ne s sa le essin  i   e  i   i a in  
 i a in  e  s e e s  e  in  alin 
i e ia el  a e  ese i n  an  en e e e  in  a a  
el  s annin  i     ke  a as an  ke  
e an  e  i a in  e s e e en l  e e   e 
a a  an  e e e  in iss e ek  si ila l  as in e ine 
l es i e  in i e  O ien a i n  e  n s as 
ain aine  in  an lin   is l  e  sa le l ks 
e e l  se i ne   e  se i ns  
is l i al an  i n is e i al s ainin s  e i a in  
l is es i e  in e ail in  an  e i sl   nkanen 
e  al   
Table 2. Characteristics of IA patients and of 
samples. 
* MCA, middle cerebral artery; AcomA,  
 anterior communicans artery; PcomA,  
 posterior communicans artery; ICA,  
 internal carotid artery; OA, opthalmic artery.
Table 3. IA samples studied. 
* Abbreviations as in Table 2.  
† ex vivo MRI performed.
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4.2 Histology and immunohistochemistry
4.2.1 Stainings
For histologic evaluation, IA sections underwent histological, 
immunohistochemical (IHC), and immunofluorescence (IF) 
stainings. Autopsied intracranial artery specimens and resected 
human tonsil tissue served as positive controls. 
4.2.1.1 Histology
The IAs were stained for hematoxylin-eosin (HE), Oil Red O 
(ORO), and Perl’s blue.
HE
All IAs were stained for Gill’s hematoxylin-eosin G. The 
IA sections were fixed in -20c° acetone for 3 min, incubated 
in hematoxylin for 5 min, washed under running tap water 
until clear, and incubated in eosin G for 2 min. The sections 
were dehydrated by traveling through ethanol baths of rising 
precentages from 50% to absolute, and by incubation in 
Ultraclear, an iso-paraffin-based clearing reagent (J.T. Baker, 
Mallinckrodt Baker, Deventer, the Netherlands). The slides were 
then mounted with J.T. Baker’s UltraKitt mounting medium. 
 
ORO
Neutral lipids were stained with ORO for unfixed cryosections 
that underwent incubation in absolute propylene glycol (Sigma, 
St Louis, MO, USA) for 5 min, then an incubation in 0.5% ORO 
solution in propylene glycol for 7 min, and then two rounds of 
washes in 85% propylene glycol, running tap water, and aqua. 
Mayer’s Hematoxylin (Sigma) background-stained the nuclei. 




Nonheme ferric (Fe3+) iron deposition, cellularly stored as 
ferritin or hemosiderin [164], was stained for Prussian blue 
using Perl’s method [164] or a modification of it by the Artisan 
Iron Stain Kit (Dako, Glostrup, Denmark) according to the 
manufacturer’s protocol. IA sections 1 to 36 were stained by the 
latter method in collaboration with the Department of Pathology, 
Helsinki University Hospital. IA sections 45 to 55 were incubated 
in 1% potassium ferrocyanide in acidic pH [164], and Nuclear Fast 
Red background-stained the nuclei.
4.2.1.2 IHC and IF
All IAs were by immunohistochemistry (IHC)-stained and 
an immunofluorescence (IF) technique served for double-
stainings (Table 4). Phases of staining protocol are explained in 
chronological order below. All incubations were performed at 
room temperature (RT) and finished, unless otherwise stated, 
with rinsing of the IA sections three times in phosphate-buffered 
saline (PBS).
Fixation
The IA sample sections were first fixed in either ice-cold 
(-20°c) acetone for 3 min, 4% paraformaldehyde for 5 to 10 min, 
formalin for 10 min, methanol for 10 min, or for 1 min in Carnoy’s 
fixative (60% EtOH, 30% chloroform, and 10% acetic acid [113]). 
Of the fixatives, acetone served as the main fixative for most IHC 
stainings, with a few exceptions: formalin was used for double-
stainings with ORO, methanol for CD34 staining, Carnoy’s 
solution for mast cell tryptase- and chymase stainings, and 
paraformaldehyde for all IF stainings. Because IAs 45 to 55 were 
originally fixed in formalin, their IHC staining was performed 
after antigen retrieval in citrate buffer. 
Blocking
For IHC, the endogenous peroxidase was blocked with either 
0.9% hydrogen peroxide (Merck, Espoo, Finland) in PBS for 20 min, 
or commercial peroxidase block solution according to the protocol 
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(EnVision kit, Dako). For IHC and IF, non-specific binding of mouse 
monoclonal antibodies was blocked with 3 to 5% normal horse serum 
(Vector Laboratories, Burlingame, CA, USA). Rabbit or guinea-pig 
polyclonal antibodies were blocked with 3-5% normal goat serum; 
1% fish skin gelatin (fatty acid-free; Sigma) completed the block in 
selected IHC stainings. All blocks were diluted in room-temperature 
buffer solution (in PBS 3% bovine serum albumin and 0.1% Tween, 
both from Sigma). Incubation time was 30-60 min. 
Antibodies
All antibodies (Table 4) were diluted in the buffer solution 
described above, and incubated for 30 to 60 min at RT, or overnight 
at 4°C. As negative controls, irrelevant IgG-class-specific monoclonal 
antibodies (IgG1 or IgG2a; Serotec, Oxford, UK) served as a substitute 
for monoclonal primary antibodies. Polyclonal primary antibodies 
were omitted in negative controls. In IHC, the primary antibodies were 
secondarily detected with either the EnVision kit or the Vectastain 
Elite ABC kit (Vector) according to manufacturers’ protocols. 
Diaminobenzidine (Vector or EnVision kit) incubation for 1 to 5 min 
visualized the signal. In IF, Alexa’s fluorescent-labeled antibodies were 
at 1:100 dilution for secondary detection of unconjugated primary 
antibodies. For the first round of double staining, either Alexa 488 
(green) F(ab’)2 fragment of goat anti-rabbit or goat anti-mouse 
IgG (Molecular Probes, Eugene, OR, USA) was used with 30 min of 
incubation. For the second round, IAs were first re-incubated with 
primary mouse anti-human antibodies similarly to the first round, and 
then with Alexa 546 (red) F(ab’)2 fragment of goat anti-mouse IgG 
secondary antibodies. Double staining combinations are in Table 5.
Background staining and embedding
For IHC, Mayer’s hematoxylin served for pan-nuclei staining, after 
which the IA sections were embedded either in Faramount aqueous 
mounting medium or, after an EtOH bath, in J.T. Baker’s UltraKitt 
mounting medium as described above. In IF, all nuclei were detected 
with DAPI (4’,6-diamidino-2-phenylindole; 1mg/ml, Sigma) in 5-min 
incubation, and finally the IA sections were mounted with a fluorescent 
mounting medium (Dako).
Table 4. Antibodies and dilutions for immunohistochemistry. 
** αSMA, α-smooth muscle cell actin; HLA-DR, Human leukocyte antigen-DR;  
 GPA, Glycophorin A; ApoA-I, Apolipoprotein A-I; ApoB-100, Apolipoprotein  
 B-100; ApoE, Apolipoprotein E; HNE, Hydroxynonenal; ABCA1, ATP-binding  
 cassette A1; HO-1, Heme oxygenase-1. 
* mouse monoclonal IgG1 
† mouse monoclonal IgG2a 
‡ rabbit polyclonal antibody 
§ guinea-pig polyclonal antibody 
‖ IgG1 and IgG2a, Irrelevant antibodies for controls, diluted to the same  
 concentration as the primary mouse monoclonal antibody of interest  
# Dako, Glostrup, Denmark; R&D Systems, MN, USA; Acris, Herford, Denmark;  
 Novus Biologicals, CO, USA; Abcam, Cambridge, UK; Serotec, Oxford, UK;  
 Novocastra, Newcastle, UK; Monosan, Uden, Netherlands; Santa Cruz  
 Biotechnology, TX, USA; Enzo Life Sciences, Farmingdale, NY, USA; LSBio,  
 Seattle, WA, USA; Merck Millipore, Darmstadt, Germany.
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4.2.1.3 IHC and ORO double-staining
Lipid-containing either CD163+, CD68+, or αSMA+ cells, foam 
cells, were identified by IHC and ORO –double-stainings, where ORO 
staining was performed on IA sections before hematoxylin incubation 
of IHC. To avoid lipid dilution, the buffer solution was prepared without 
Tween, and formalin served as fixative.
4.2.2 Histological evaluation
For analysis, the histological and IHC stains were microscoped 
and photomicrographed with a Zeiss Axioplan 2 imaging microscope 
(Flokal Bv Micro-optik, Deursen, The Netherlands) and a Progres C7 
USB digital camera (Jenoptik, Jena, Germany). The stained IA sections 
of the MRI-imaged IAs were imaged with a Hamamatsu Nano-Zoomer 
XR digital histo scanner, and the Hamamatsu viewer program. The 
IF stains were photomicrographed with a 3DHISTECH Pannoramic 
250 FLASH II digital slide scanner (Genome Biology Unit, University 
of Helsinki) and the Pannoramic viewer program. See Table 5 for the 
histological analysis.
IA wall structure
Three blinded observers (E.O., R.T., and J.F.) evaluated the wall 
structure for the dominant wall type. IAs 1 to 44 were classified as A, B, 
or C in type according to Frösen criteria [70] (details in Figure 9). Of 
the IAs, only two samples were representative for type D, and thus were 
excluded from wall-type analysis. Another three IA samples were poorly 
oriented for wall-type evaluation, and thus excluded from this analysis. 
Additionally, the IAs were scored for the presence or absence 
of myointimal hyperplasia, decellularization, fibrosis, and fresh or 
organized thrombosis. The status of luminal endothelium was scored 
according to the presence or absence of an intact monolayer of CD31 
(platelet endothelial cell adhesion molecule-1, PECAM-1 [256]) -positive 
cells on the luminal surface of the IA wall. 
Number	of	Inflammatory	Cells
The number of CD68+, CD163+, CD3+, and CD45+ cells and MCs 
(tryptase+ cells) were counted in three standard-sized (0.613 mm2) 
areas of hot spots, representing the areas most intensely stained for the 
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cells of interest. In a few IAs, the number of analyzed hot spots had to 
be restricted because of small sample size. Any thrombus present was 
excluded from the cell-count analysis. Additionally, distribution density 
of MCs in the IA wall was defined as MCs per mm2 using ImageJ, NIH 
Software. Chymase+ MCs were counted separately. Degranulated MCs 
were identified as cells showing pericellular staining positive for either 
tryptase or chymase [117]. IAs 1 to 36 were analyzed for all the leukocyte 
markers, and IAs 37 to 44 for CD45+ cells.
Extent	and	pattern	of	lipid	accumulation	markers
The presence or absence of ORO-positive neutral lipid accumulation 
was defined as was its intracellular or extracellular localization. The 
extent of ORO-positive area in the IA wall was measured as a percentage 
of the total surface area of an IA wall section (ImageJ). The relative 
positively stained areas for apoA-I, apoB-100, HNE, and adipophilin 
underwent measurement similarly to that of ORO. ApoE was analyzed 
for the presence or absence of colocalization or partial colocalization 
with apoA-I and apoB-100 in consecutive sections. All lipid markers 
were analyzed from IAs 1 to 36.
Iron deposition 
To identify the presence of iron deposits, a Prussian blue-positive 
signal was sought from several serial IA sections from IAs 1 to 36 and 45 
to 55. IAs with strong, widespread iron deposition with large deposits 
were considered to contain significant deposition of iron, whereas IAs 
containing only a few spots of faint positive staining underwent separate 
analysis.
Presence	and	density	of	neovascularization
Neovascularization, i.e. the presence of CD31- or CD34-positive 
capillary-like structures with lumens [107,159,179,256], was analyzed 
from the IAs 1 to 36. The number of neovessels per mm2 (ImageJ) 
defined their distribution density, similar to that of MCs. CD34-
positive structures showing a branching morphology without a 
lumen were analyzed separately. 
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Semiquantitative Analyses
Each variable was scored for the presence or absence of positive 
staining in the IA wall, the localization: intracellular or extracellular 
or both, of the positive staining, as well as whether the signal was 
located in the IA wall or in the thrombus or both. Several variables 
were further scored semiquantitatively to define the extent of 
positive signal in the IA wall. Thereafter, IAs stained for αSMA, 
HLA-DR, ABCA-1, GPA, or HO-1 were divided into 3 to 5 categories 
based on the presence and extent of the variable analyzed. 
Of the semiquantitatively scored variables, the cellularly localized 
ones: αSMA+, HLA-DR+, and ABCA+, were scored based on the amount 
or extent of positively stained cells. For αSMA+ cells, the IAs were 
divided into five groups: 1, none; 2, a small group or a few scattered or 
both; 3, scarce; 4, extensive presence; or 5, increased density of αSMA+ 
cells (SMCs) throughout the wall. HLA-DR+ cells were always present, 
either 1, in a retricted wall area; 2, widely spread or densely in parts 
of the wall; 3, densely throughout the wall. The score of ABCA1+ cells 
was either: 1, none; 2, a few; 3, a small dense group or few scattered 
positively stained cells or both; 4, dense accumulation in half the wall 
area or numerous scattered cells in the whole wall area or both; or 5, 
dense accumulation in the whole wall area. 
The amount of either GPA+ or HO-1+ signal in the IA wall 
was scored based on the extent of positive staining, due to either 
intracellular or extracellular localization of these variables. For 
GPA, the extent of positive stainings was either: 1, none, 2, faint 
in a restricted wall area; 3, less than half the sIA wall area; or 4, 
more than half the sIA wall area. For HO-1, the scores were: 1, no 
positive staining; 2, scattered positive cells in a restricted wall area; 
3, either scattered positive cells throughout the wall or intracellular 
and extracellular staining in parts of the wall; 4, positive staining 
throughout the wall.
Colocalizations of the positively stained areas were defined from 
adjacent sections of IHC stainings of the variables: GPA, HO-1, and 
HLA-DR stains were scored for colocalization with CD163+, CD68+, 
or αSMA+ cells as absent, partial, or complete.
The number of ORO+ lipid-containing CD163+, CD68+, or αSMA+ 
foam cells was scored either as 1, none; 2, a few < 5; 3, a small dense 
group or solitary scattered cells or both; or 4, numerous and widely 
spread double-positive cells in the IA wall.
Table 5. Histological and immunohistochemical evaluation of stainings. 
* Double-stainings: αSMA with CD163, ABCA1, GPA, HO- 
 1, and ORO; CD163 with αSMA, ABCA1, GPA and  
 ORO; CD68 with ABCA1 and ORO. 
† binary; presence or absence 
‡ semiquantitative 
§ number of cells in 1-3 hotspots, each 0.613 mm2 
# distribution density in the whole IA wall section, i.e.  
 number of cells or structures per mm2 
‖  percentage of positively stained area in the IA section
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4.3 Computational Flow Dynamic models
Patients’ preoperative 3D CTA images of approximately 250 
axial sections (512 x 512 pixels and 0.4 x 0.4 x 0.6 mm voxel 
resolution) served as a data source for computational fluid dynamics 
(CFD) models (III). The flow models were constructed in the 
Bioengineering Departments of George Mason University, Fairfax, 
Virginia, USA. The geometrics of the IAs and parent arteries were 
segmented from CTA raw data at 0.625-mm slice thickness. Mesh 
generation and computational fluid modeling were as described 
previously [36,37]. The mathematical simulations of pulsatile 
flows [176] and the fluid dynamic variables for intra-aneurysmal 
environment were as described by Mut et al. [177]. Principles for 
inflow and outflow rates were defined according to the Murray law 
[174], and inflow boundary conditions according to Taylor et al. 
[239]. Flow waveform models originated from healthy subjects, as 
described by Cebral et al. [36].
To define the degree of wall shear-stress (WSS), the IAs were 
divided into three groups with different levels of WSS according 
to the median WSS (8.9 dyne/cm2, SD 12.6 dyne/cm2). Low-WSS 
level was <4.5 dyne/cm2, mid-WSS level was between 4.5 dyne/cm2 
and 18.0 dyne/cm2, and high-WSS level was >18.0 dyne/cm2. The 
WSS-level groups were correlated with IA wall type and number of 
inflammatory cells. Degree of inflammation was characterized as 
little or substantial according to the number of CD45+ cells (lower or 
higher than the median) to compare the hemodynamic changes in 
different stages of inflammation.
Blood flow was characterized over time (systole-diastole) and 
space (IA volume from neck to fundus) and determined focally 
in various regions within the IA sack. The flow was defined as 
homogenous according to mean flow over time spatial average 
<0.5 dyne/cm2 or the average <3 dyne/cm2; otherwise, flow 
was considered heterogeneous. The degree of inflammation was 
considered as homogenous, if the number of CD45+ cells in the two 
or three hotspots of the IA wall remained constant (between the 
threshold values 10 and 200). Of the 20 IAs, 2 were excluded from 
this analysis due to small sample size, and only one hotspot was 
analyzed.
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4.4 Ex vivo MRI
After their resection, fixation, and embedding, IAs 45 to 55 
were imaged with MRI (Figure 14) by Petri Honkanen, MD, 
similarly as earlier [91] with two iron-sensitive sequences: 1. A 
T1- or T2-weighted fast-spin echo sequence with rapid acquisition 
and relaxation enhancement (RARE), and 2. A T2* gradient echo 
sequence with a fast low-angle shot (FLASH) in a linear birdcage 
radiofrequency coil with inner diameter of 60 mm.
4.4.1 Imaging protocol
The factors for T1-weighted RARE images were TE 10 ms, TR 
600 ms, 5 excitations, echo train length 4; and for T2-weighted 
RARE images: TE 40 ms, TR 2600 ms, 10 excitations, flip angle 90o, 
echo train length 8; and for proton-density-weighted RARE images: 
TE 10 ms, TR 3000 ms, 3 excitations, echo train length 4. For T2*-
weighted FLASH images, the factors were TE 8 ms, TR 500 ms, 4 
excitations, flip angle 40o. For all MRI sequences, matrix size was 
265 x 265, and slice thickness 1 mm. The MR images were reviewed 
with OsiriX software (free version). 
4.4.2 Analysis of MRI-scanned IA subseries
After imaging, the IAs were cryosectioned each in the same 
orientation into 10μm sections. Corresponding to each MRI image, 
the positive signal of GPA and Prussian blue were evaluated from the 
serial histological sections, for GPA using immunostaining and Perl’s 
method. 
For comparison of histology with MR images, each MR image 
was paired with its corresponding histological section. In this MR 
image series of each IA, the first and last images of the series of 
adjacent sections were usually images of tangentially cut IA sections. 
Since these peripheral pieces of the IA wall showed no informative 
crosscut of the wall structure, they were excluded from further 
analysis. Finally, in total 48 MR images from 11 IAs were evaluated.
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4.4.2.1 Visuospatial comparison of histology and MRI presentation
All histological sections, stained either for GPA or Prussian blue, 
were compared with their corresponding MRI images to assess the 
appearance of these two erythrocyte markers in MRI. Orientation of 
the IA wall section and the localization of corresponding wall areas 
were identified to find correlations between the histological and MRI 
presentations.  
4.4.2.2 Statistical comparison of histology and MRI signal intensity
In the MR images, the presence or absence of susceptibility artifacts, 
considered as black areas within the IA, was observed. Additionally, 
areas showing heterogenous signal intensities wihin the total IA section 
area were defined as either 1, hypointense: darker than the background; 
2, isointense: similar to the background; 3, or hyperintense: brighter 
than the background. By “background” this means the agar gel 
surrounding the IA section in the image. The extent of areas showing 
different signal intensities within the IAs in MR images were scored 
semiquantitatively. Thus, all 48 MR images were scored for the presence 
or absence of any particular signal intensity. If present, the extent of the 
IA wall area showing the particular signal intensity was scored either as 
1, less than half the IA wall area; or 2, more than half the IA wall area 
of the section. Finally, MRI signal intensity scores were compared with 
the histological scores of GPA and Prussian blue in the corresponding 
sections, independent of their visuospatial colocalization or lack of it. 
4.5 Statistics
IBM SPSS Statistics Software (version 21; IBM Corporation) 
served for data analysis. Fisher’s exact test served for calculating the 
proportions of categorical variables, and the Mann-Whitney U-test and 
Kruskall-Wallis multiple comparison tests compared categorical and 
continuous variables. Continuous and semiquantitative variables were 
correlated by the Spearman correlation test. Median and range were 
calculated for continuous variables.  The α-level was 0.05.
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5. Results and 
Discussion
5.1 Clinical and macroscopic features of the 
IAs
5.1.1 Risk factors and IA rupture
The 55 patients with saccular intracranial aneurysms (IAs), 25 
unruptured (45%), and 30 ruptured (55%), studied for degenerative 
wall changes in histology (I-IV), flow conditions in the IA lumen 
(III), or magnetic resonance imaging (MRI) of the IA wall (IV), did 
not significantly differ in sex, age, smoking status, or hypertension 
(Table 6). These findings suggest that in this group of patients, 
the main clinical risk factors for IA prevalence and rupture did 
not associate with IA rupture. Values for plasma total cholesterol, 
triglycerides, and low- and high-density lipoproteins (LDL and HDL) 
were available for 21 patients with 12 unruptured and 9 ruptured 
IAs (II), and these levels similarly failed to associate with IA rupture 
(Table 6).
Among the 36 samples studied in I-II and IV, the location and 
size of an IA neither associated with wall rupture (I), nor did the 
PHASES score [185], which sums up the effect of selected risk factors 
for IA rupture: Population, Hypertension, Age, Size of an aneurysm, 
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Earlier SAH from another aneurysm, or Site of an aneurysm [77] 
(Table 6). Thus, the risk factors studied could not have predicted IA 
rupture in this series of patients and IAs. This supports a demand 
for other tools for risk prediction, ones requiring better knowledge 
of potential risk factors and biomarkers predictive for aneurysm 
rupture. 
5.1.1.1 Multiple IAs
Of the patients, those with an unruptured IA showed IA 
multiplicity more often than did those with a ruptured IA (I) (Table 6) 
(Figure 15). Previous subarachnoidal hemorrhage (SAH) showed no 
association with IA multiplicity (p=0.144, unpublished data). Selection 
bias should therefore not explain the finding of multiple incidental IAs 
due to imaging of the previous SAH. A possibility exists that patients 
showing multiple unruptured IAs would have a systemic etiology or 
a risk factor behind their IAs more often than would those patients 
who develop only one IA. However, IA multiplicity did not associate 
with these classical risk factors (p>0.086 for all), and this does not 
therefore seem to offer an explanation for any potential systemic 
cause. The cause for multiple IAs thus remains unknown.
5.2 Degenerative remodeling of the IA wall
Histological changes in the IA wall were most extensively studied 
in IA samples 1 to 36 (I, II, IV). Wall type and thrombosis were 
identified also in IAs 37 to 44 (III).
5.2.1 Structural changes in IA walls
Most IAs showed IA wall changes such as loss of endothelium, 
degenerative or proliferative remodeling of the wall or both, and a 
luminal thrombus [70,116] (Figure 16).
5.2.1.1 Endothelial erosion, thrombosis, and SMC remodeling 
Most IAs (26 of 36; 72%) had lost their intact luminal 
endothelium, based on the absence of a CD31+ cell monolayer 
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Table 6. Clinical characteristics of 55 (unruptured 25 or ruptured 30) 
saccular intracranial artery aneurysms (IAs).
* p ≤ 0.05 considered significant. 
† Fisher’s exact test, proportions given. 
‡ Mann-Whitney U-test, median and range for continuous variables. 
§ N=36 (samples 1-36) 
# N=21 
‖ N=44 (samples 1-44)
Figure 16. Images of IA wall structural features. a, CD31+ endothelium (brown) in 
the luminal surface of a type A aneurysm with a linearly organized wall 
structure; b, hyperproliferative and disorganized αSMA+ SMC pattern 
(brown) in type B wall; c, an unruptured type C IA wall, showing a thick, 
hypocellular wall structure (arrow) and αSMA+ cells (arrowheads) in both 
luminal and adventitial sides of the wall; d, another unruptured IA wall with 
a thrombus; e, CD31+ adventitial vasa vasori or neovessels in the IA wall 
and a high number of surrounding inflammatory cells also staining positive 
for CD31; f a ruptured IA, stained for αSMA (red, immunofluorescence 
staining). Negative control (DAPI) is the inset of f, and i and ii show 
close-up images of αSMA+ cells, likely SMCs, and αSMA+ small vessels. 
Descriptions for IA wall types are in 5.2.1.2.
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in the luminal surface of the IA wall (I). Ruptured IAs showed 
such endothelial erosion more often than did unruptured IAs, 
supporting previous findings [71], although the finding here did 
not reach statistical significance (Table 7). The platelet endothelial 
cell adhesion molecule-1 (PECAM-1, i.e. CD31), together with the 
vascular cell adhesion molecule-1 (VCAM-1) [142], mediates various 
regulatory functions of endothelial cells responding to vascular 
wall shear stress, leukocyte transmigration, and thrombosis [256]. 
Regulation of these barrier functions may thus be disturbed in those 
IAs lacking an intact endothelium.
An intraluminal thrombus was present in 17 of 42 (40%) of the 
IAs (I, III). Two of the 44 IAs remained unclear for the presence (or 
absence) of thrombosis, due to their complex wall orientation. Of 
the thrombosed IAs, 14 showed a fresh (young) thrombus and 14 
an organizing (older) thrombus. Notably, thrombus organization 
suggested that thrombosis was not only secondary to the acute IA 
bleeding, but instead, it had occurred slowly during IA formation. 
Any thrombus, whether fresh or organized, was associated with IA 
wall rupture (Table 7).
Mural α-smooth muscle cell actin (αSMA) -expressing cells were 
present in the wall, but also in the organized thrombus. Even though 
macrophages can express αSMA in a murine model of atherosclerosis 
[1,63] and potentially also in humans [74], the αSMA+ cells were 
considered to be smooth-muscle cells (SMCs), based on their 
morphology in relation to the general histological appeareance of the 
samples. SMCs located in the thrombus seemed to originate from the 
adjacent aneurysm wall. In atherosclerotic arteries, the thrombus 
is known to secrete growth factors such as platelet-derived growth 
factor (PDGF) and transforming growth factor beta (TGF-b), which 
can potentiate SMC proliferation and migration [142]. Frösen et al. 
demonstrated the expression of PDGF and TGF-b receptors in the 
area of myointimal hyperplasia and organizing thrombus of ruptured 
IA walls [69], proposing the activity of these growth factors in the IA 
wall, thus potentially triggering SMC migration and proliferation. 
Loss of SMCs occurred to a variable degree in the majority of IAs 
(26/36, 72%), but the semiquantitative SMC score did not associate 
with IA rupture (p=0.321, Fisher) (II). SMC disorganization was, 
however, more common in ruptured than in unruptured walls (I) 
(Table 7). Changes in SMC organization may reflect a shift in SMC 
Table 7. Histological changes in unruptured and ruptured saccular intracranial artery 
aneurysms (IAs). Modified from data in tables of Studies I and II.
† Fisher’s exact test, proportions given.  
‡ Mann-Whitney U-test, median and range for continuous  
 variables.  
§ In standard-sized areas of 0.613 mm2.
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phenotype from the contractile to the synthetic type [39,49], which 
may occur in the IA wall and contribute to wall fragility. 
5.2.1.2 Distribution of IA wall types
Aneurysm walls 1 to 44 were classified according to wall-type 
criteria described by Frösen et al. [70] (I, III). Three IAs were 
excluded from analysis due to their unfavorable orientation in the 
tissue block. Among the other 41 IAs, 9 (22%) represented type-A 
walls, with an intact endothelium and linearly organized SMCs; 17 
(41%) represented type-B walls, with a thickened, hyperproliferative 
wall with disorganized SMCs; and 13 (32%) type-C walls, showing 
a hypocellular wall, accompanied by either myointimal hyperplasia 
or an organizing luminal thrombus. Only 2 (5%) of the IAs were 
representative of the most degenerated type-D walls, showing an 
extremely thin, hypocellular wall with a luminal thrombus. Due to 
the small number of type-D samples, they were excluded from wall-
type analysis. Both type-D IAs were ruptured.
Wall type did not associate with IA clinical risk factors (Table 
8). Notably, the presence of clinical risk factors was associated 
neither with IA rupture (see 5.1.1) nor with wall type, the latter of 
which may also predict the rupture risk of an IA, based on degree of 
degenerative IA-wall changes [70]. IAs have indeed demonstrated 
a gradual risk increase for IA rupture from type A to D [70]. In this 
IA series, wall type did not associate with IA rupture statistically 
significantly (Table 8), although the evident trend suggests these 
findings as in line with those [70].
5.2.2 Neovascularization in the IA wall
Of 36 IAs, 15 (42%) contained CD34+ or CD31+ capillarylike 
structures, indicating the presence of neovessels (I) (Figure 17). 
Hematopoietic progenitor cells of immature endothelial structures 
express CD34 [107], whereas CD31 is expressed by mature 
endothelial cells [256]. Therefore, both CD34+ and CD31+ capillaries 
sought from adjacent histological sections were considered to be 
neovessels of potentially different maturation stages [159,170]. 
The final quantitative analysis of these neovessels was based on 
the number of CD34+ neovessels alone, since they predominated 
Table 8. Distribution of clinical characteristics in saccular intracranial artery 
aneurysm (IA) wall types A, B, and C.
† Fisher’s exact test, proportions given. 
‡ Kruskal-Wallis test, median and range for continuous variables. 
§ N=36 (samples 1-36) 
# N=21 
‖ N=44 (samples 1-44)
96
in 14 of the 15 IAs, with only one IA showing a single CD31+ vessel 
without any CD34+ neovessels. This single IA was excluded from 
quantitative analysis. In the IA walls adjacent to neovessels, 
additional CD34+ continuous structures without a capillary lumen 
were abundant. These were often located adventitially in the IA wall. 
In the neovascularization process known to occur in atherosclerotic 
artery walls, neovascularization starts as endothelial sprouting from 
the adventitial vasa vasori [170], and the newly developed neovessel 
branches invade through the media towards the thickened intima 
[170,206]. Thus, the branching CD34+ structures in neovascularized 
areas of the IA walls are interpreted as early-stage neovessels 
[56,170]. These findings suggest ongoing neovascularization in the 
majority of the IA walls, in 28 of 36 (78%).
The presence of or density of neovessels and the other CD34+ 
structures considered as pre-vessels was not associated with IA 
rupture (Table 7) However, neovascularization did associate with IA 
wall degeneration, with the density of neovessels being the highest 
in type-C walls (Table 9). The IA is likely to suffer from hypoxic 
conditions, based on its expression of hypoxia inducible factor-1 
(HIF-1) [132], a potential trigger for neovascularization. In addition 
to HIF-1, activity of angiogenic growth factors PDGF and vascular 
endothelial growth factor (VEGF) may occur in the IA wall [69], and 
thus they may mediate neovascularization there.
In the present study (I), neovessel density correlated with the 
presence of mast cells (MCs, p<0.001) and with the number of 
CD163+, CD68+, and CD3+ inflammatory cells in the IA wall (r=0.617-
0.669, p<0.001, Spearman, unpublished correlation). The presence 
of neovessels in human IAs has been reported in association 
with leukocytes [90]. These findings suggest the contribution of 
inflammation to neovascularization. In atherosclerotic arterial walls, 
inflammatory cells secrete several pro-angiogenic factors among 
their cytokines and chemokines, ones such as VEGF, PDGF, TNF-α, 
and MMPs [206], which may mediate neovascularization also in the 
IA walls. On the other hand, neovessels can facilitate the entry of 
circulating inflammatory cells into the IA wall [224,250], which thus 
may cause neovessel rupture and microhemorrhages in the vascular 
wall [206], as described in the following section.
Figure 17. Neovessels and microhemorrhages in the IA wall. a, CD34+ structures with a lumen (arrowhead), 
considered as neovessels; b, CD34+ continuous structures without a lumen (arrowhead), considered 
as developing neovascular structures or early neovessels, potentially sprouting from adventitial vasa 
vasori (not shown here); c, strong iron (hemosiderin) deposition in the area of the suspected early 
neovascularization; d, inset, close-up of iron deposition.
Table 9. Distribution of wall remodeling changes, ones not included in the wall type criteria, in saccular 
intracranial artery aneurysm (IA) wall types A, B, and C. Modified from tables of Studies I and II.
† Fisher’s exact test, proportions given. 
‡ Kruskal Wallis test, median and range for continuous variables. 
§ In standard-sized areas of 0.613 mm2. 
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5.2.2.1 Microhemorrhages from leaky neovessels 
Of the 47 IAs, Prussian-blue-positive staining occurred 
in 20 (43%), reflecting deposition of ferric iron in the form 
of hemosiderin (I, IV). Notably, hemosiderin was sought 
systematically from several IA wall levels throughout IA sample 
blocks 45 to 55, and all of these IAs showed positive staining, 
whereas from IAs 1 to 36 only two sections stained, and of these 36, 
9 IAs showed hemosiderin deposition. Thus, the number of stained 
sections possibly affected the sensitivity of finding hemosiderin. 
Nevertheless, the amount of hemosiderin per section in most cases 
was small. 
Of the 20 IAs, 7 showed local, strong iron positivity in their 
large hemosiderin deposits, whereas the other 13 IAs showed weak 
positive staining. That some of the large iron deposits were located 
intracellularly suggests the intracellular storing of hemosiderin 
following lysosomal degradation of hemoglobin [164,165,195]. The 
presence of extracellular iron deposition in the IA wall indicates 
phagocytic release of hemosiderin [263]. 
The strong iron deposition colocalized with neovessels in the 6 
of the 36 IAs that stained for both (I), and strong iron deposition 
associated with neovessel density (p<0.001) and wall degeneration 
(Table 9). Newly formed neovessels can leak erythrocytes into 
the arterial wall, producing microhemorrhages [165,224], which 
implies that leaky neovessels are a cause for microhemorrhages in 
the IA walls. Another potential source of iron accumulation is the 
hemoglobin originating from erythrocytes trapped in the luminal 
thrombus.
5.3 Lipid load as a possible promoter of IA 
wall rupture
Lipid accumulation, a core phenomenon of atherosclerotic plaque 
formation, is known to occur in the IA wall and may play a role in IA 
wall pathogenesis [71,72,125,244].
Figure 18. Lipid accumulation in the IA wall. Representative images of a, 
apoB-100+ lipoprotein particles, b, ORO+ neutral lipid (arrow), 
and c HNE+ oxidized lipid retention in the IA wall. Images d-f 
show adjacent sections from the same area of an IA wall. 
Double-stainings of ORO with d, CD68+ and e, aSMA+ cells 
demonstrate intracellular lipid accumulation in these cells; and f, 
expression of ABCA-1 lipid transporter suggests its upregulation 
potentially by foam cells in the IA wall; g and h show intracellular 
lipid accumulation at higher magnification. i ApoA-I was focally 
distributed in the IA wall, and j, adipophilin often showed 
widespread extracellular accumulation in hypocellular wall areas, 
suggesting foam cell death in that area. All scale bars 50 µm.
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5.3.1 Lipid accumulation broadly present in degenerated 
IA walls
Accumulation of lipids or their circulatory carrier particles, 
apolipoproteins, appeared to a variable extent in all 36 IA walls 
(II). These lipid or apolipoprotein particles were retained both 
intracellularly and extracellularly, irrespective of plasma lipid 
levels, as in earlier observations [72]. This suggests that the local 
pathological conditions in the IA wall, like its structural remodeling 
and proinflammatory microenvironment, contribute to the influx 
and retention of lipids, favoring a non-physiological accumulation 
of lipids. Figure 18 demonstrates accumulation patterns of the lipid 
markers in the IA wall. 
5.3.1.1 Apolipoprotein B and lipid influx in the IA wall
Apolipoprotein B-100 (apoB-100) was present in all 36 IA walls, 
reflecting retention of atherogenic very low-, intermediate-, and 
low-density lipoprotein particles (VLDL, IDL, and LDL) (II). These 
lipoproteins carry lipids from the circulation to the arterial walls 
[129,144], and apparently also to the IA walls. Tulamo, and Frösen, 
et al. have shown apoB-100 in the IA wall [72,244] and this study 
highlights its extensive retention in the wall. The median proportion 
of IA wall area staining positive for apoB-100 was 16%, ranging from 
0 to 89%. In three IAs (8.3%), the positive staining was restricted 
only intracellularly to a few positively staining mural cells.
Especially those IA walls lacking intact endothelium showed the 
most extensive accumulation of apoB-100 (median area 25% vs. 
8%, p=0.001). Disturbed barrier function or total loss of luminal 
endothelium predisposes the arterial wall to lipoprotein influx 
from the circulation [7], indicating that endothelial erosion may 
contribute to apoB-100 lipoprotein accumulation in the IA wall. 
An organized thrombus associated with apoB-100 accumulation 
(p=0.009), indicated endothelial erosion prior to thrombosis and 
thus supports this interpretation. Moreover, the thrombus itself 
may become a source of lipids by trapping erythrocytes whose lysis 
releases cholesterol from cell membranes [250].
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5.3.1.2 Neutral lipid accumulation
The vast majority of the IAs showed an accumulation of Oil red 
O (ORO) positive lipid, reflecting accumulation of cholesterol esters 
and triglycerides, i.e. neutral lipids. Specifically, of 36, 28 (78%) 
showed extracellular ORO+ lipid when stained at one section level 
per sample (I), and 33 (92%) showed ORO+ when stained at several 
IA section levels (II). The atherogenic LDL particles contain high 
quantities of triglycerides and cholesterol covered by a phospholipid 
layer and integral apoB-100 [73]. The association of ORO+ lipids with 
apoB-100 (r=0.400, p=0.016, unpublished correlation) suggests that 
at least some neutral lipids in the IA wall have derived from apoB-
100-containing lipoprotein particles. 
Accumulation of neutral lipids did not associate with IA wall 
rupture, nor did the apoB-100 retention in the IA wall (Table 7). 
However, ORO+ lipid was particularly retained in hypocellular areas 
and was spread most extensively in degenerated (C-type) IAs (Table 
9). Tulamo et al. have shown that a similar ORO+ lipid retention area 
colocalizes with the terminal complement activation complex C5b-9 
that is associated with chronic inflammation and IA rupture [244]. 
Frösen et al. have demonstrated that accumulation of neutral lipids 
in the aneurysm wall is associated with loss of mural cells, suggesting 
that a lipid-induced proinflammatory or cytoxic stimulus may trigger 
degenerative remodeling of the aneurysm wall [72].
5.3.1.3 Oxidized lipids, lipid phagocytosis, and foam cell death
That 35 IA walls (97%) showed the presence of extracellular and 
intracellular hydroxynonenal (HNE) (II) indicates the presence 
of oxidized lipids in the IA wall [188]. The median extent of HNE 
retention was 10% (range 0-92%) of the IA wall area. Retention of 
oxidized lipids was the highest in type-C walls (Table 9), reflecting 
the association of retention with IA wall degeneration. Oxidative 
stress causes modification of proteoglycan-bound lipids and 
lipoproteins [225], facilitating their retention, and triggering their 
phagocytosis by macrophages and mural SMCs in the arterial wall 
[141]. 
The IAs contained an intracellular accumulation of ORO, apoB-
100, and HNE, indicating the presence of lipid-laden foam cells. 
Immuno-double-stainings with ORO revealed ORO+/ CD68+, 
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CD163+, and aSMA+ cells, suggesting lipid ingestion by both 
macrophages and SMCs in the IA walls (II). Macrophage-driven 
phagocytosis is an essential mechanism for lipid clearance from the 
arterial wall, preventing the formation of a necrotic lipid core in the 
atherosclerotic plaque [80,129,143]. Notably, of the 36 IAs, 16 (44%) 
contained SMC foam cells (II). SMCs containing HNE+ oxidized 
lipids have also been detectable in the IA wall [72]. These findings 
suggest a role for SMCs as lipid-phagocytosing cells in the IA walls.
IAs containing SMC foam cells showed a marked loss of mural 
SMCs (p=0.011), suggesting the cytotoxicity of intracellular lipid 
accumulation. Furthermore, loss of SMCs was associated with 
accumulation of neutral lipids (p=0.027) and oxidized lipids 
(p=0.009).  Ingestion of cytotoxic lipids may contribute to the 
death of SMCs by disturbing their normal cellular functions 
[237]. The finding that not only oxidized lipid but also apoB-100 
was occasionally present in the cell cytoplasm (II) suggests that 
lipoprotein oxidation and retention possibly disturbs lysosomal 
processing of lipoprotein particles [30,106,150]. In short, excess lipid 
load may cause intracellular lipid retention and associated cell death 
in the IA wall. 
Once phagocytozed, intracellular lipid droplets become 
covered by adipophilin [87]. Adipophilin was expressed also in 35 
(97%) of the 36 IAs, where it was located mainly extracellularly 
(II), suggesting the release of adipophilin-containing lipids from 
the cells either by active exocytosis or at their death. Extent of 
adipophilin (median 13%, range 0-87%) associated also with loss of 
SMCs (p=0.011) and IA wall rupture (Table 7). The observation of 
extracellular adipophilin surrounding adipophilin-expressing foam 
cells indicates the release of adipophilin-attached lipid droplets 
into the ECM, most likely as a result of lipid-laden foam-cell death 
[41,129,141,237], potentially predisposing to IA wall rupture, in line 
with findings by Frösen et al. [72].
5.3.2 Cellular lipid clearance pathway in the IA wall
Apolipoprotein A-I (apoA-I), the protein component of high-
density lipoprotein (HDL), existed in all IAs (II). ApoA-I was mainly 
located in the ECM, and its presence was most widespread in the 
degenerated IA walls (Table 9), which also contained an abundant 
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accumulation of lipids. The widespread presence of apoA-I (median 
56%, range 0-100%) indicated the presence of the reverse cholesterol 
transport pathway of intracellularly accumulated lipids [7]. To 
perform the cellular lipid clearance, apoA-I itself does not enter 
the foam cell, as it operates through the cell membrane transporter 
ATP binding cassette-1 (ABCA-1) [7,211]. Of the IA walls, 33 (92%) 
expressed also ABCA-1 (II), indicating the capacity for release of 
intracellular lipids via interaction with apoA-I. The amount of 
ABCA-1 associated with oxidized lipids and adipophilin suggests that 
intracellular lipid accumulation was associated with the presence of 
apoA-I and the ABCA-1 clearance pathway.
5.3.2.1 Impaired apolipoprotein A-mediated lipid clearance
Contrary to the lipid clearance function of apoA-I, those IAs 
with massive infiltration of apoA-I also showed massive lipid 
accumulation and wall degeneration. Such a finding indicates 
insufficient function or failure of the apoA-I–ABCA-1-mediated 
clearance mechanism, especially as apoA-I and ABCA-1 accumulated 
in different wall areas in nearly half of the IAs expressing them both. 
These observations indicated lack of the apoA-I–ABCA-1 interaction 
in those wall areas. The colocalization of ABCA-1-expressing and 
apoA-I-containing wall areas associated with a higher amount of 
SMCs in the IA wall (p=0.003), whereas the supposed functional 
lack of this colocalization associated with wall degeneration 
(p=0.017) (II). This finding supports the interpretation that failure of 
intracellular lipid clearance predisposes SMCs to death by lipids. 
In part, the supposed failure of apoA-I function could be 
explained by the observed non-physiological distribution observed 
of apoA-I in the IA wall. Normally the small-sized apoA-I particle 
diffuses freely through the arterial wall, without binding to the ECM 
[7,211]. However, apoA-I showed focal distribution in the IA wall, 
raising the suspicion of its abnormal retention in the IA wall. Binding 
of apoA-I to ECM is possible via the apoE particle [181]. In the 
IAs, however, apoA-I+ wall areas colocalized only partly with apoE+ 
staining, and thus attachment of apoA-I to apoE could not fully 
explain the localized apoA-I pattern (II). Other factors may therefore 
be disturbing apoA-I function in the IA wall, factors such as oxidative 
stress. Thus, besides lacking interaction with ABCA-1, apoA-I 
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may have become dysfunctional itself, due to the pro-oxidative 
environment of the IA wall. ApoA-I has normally anti-oxidant and 
anti-inflammatory properties in the arterial wall in addition to its 
anti-atherosclerotic function [7,211]. The shift of apoA-I into its 
dysfunctional and proinflammatory form has been described in 
atherosclerotic arteries and AAAs, especially in the presence of 
oxidizing myeloperoxidase (MPO) [93,178,211]. Since MPO has been 
detectable in human IAs [76], and these IAs also contain MPO [185], 
oxidation of apoA-I may have occurred in the IA wall, thus triggering 
the apoA-I retention. 
Another potential mechanism for impaired lipid clearance 
from SMCs is their downregulated ABCA-1 expression. In the IA 
wall, ABCA-1 expression correlated positively with the number of 
CD68+ (p=0.005) and CD163+ (p=0.001) macrophages, suggesting 
upregulation of ABCA-1 by macrophages. However, because high 
expression of ABCA-1 did not correlate with high amount of SMCs 
in the IA wall (p=0.075), intracellular lipid accumulation may 
upregulate ABCA-1 expression in macrophages, but not necessarily 
in SMCs in the IA walls; this is a phenomenon recently demonstrated 
in advanced atherosclerotic lesions, where intimal SMC foam cells 
showed reduced ABCA-1 expression in comparison to myeloid 
lineage inflammatory cells [5]. Such a reduced capacity for 
upregulated ABCA-1 expression by SMC foam cells may occur also in 
the IA walls, since only solitary cells double-positive for aSMA and 
ABCA-1 appeared (II).
In short, apoA-I function via ABCA-1 may be a significant lipid 
clearance mechanism in the IA wall, and the lack or dysfunction of 
this protective mechanism may contribute to excess lipid load and to 
SMC death.
5.4 Erythrocytes as a source of oxidative 
stress
Of the IAs, 40% contained fresh or luminal thrombus and a 
thrombus associated with IA rupture (see 5.2.1.1). Thrombi appear 
as a potent source of oxidative stress in the IA walls, since they 
contained erythrocytes. Erythrocyte-derived heme is an effective 
oxidant.
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5.4.1 Eryhtrocytes originating from the thrombus and 
neovessels 
Glycophorin A (GPA), an erythrocyte-specific cell membrane 
component [120], was present in the majority (34 of 36, 94%) of 
the IA walls, reflecting the accumulation of either intact or lysed 
erythrocytes (IV). Erythrocyte accumulation was abundant in 
the luminal thrombus in the IAs, suggesting the thrombus as a 
significant source of erythrocyte membrane fragments, as it is in 
intraplaque hemorrhages in atherosclerotic arteries [165]. In the 
IAs especially, organized thrombus associated strongly with GPA 
score (p<0.001). This finding highlights erythrocyte accumulation 
as a long-term factor in IA wall pathogenesis as a component of old 
thrombus, rather than as representing acute repair of intraluminal 
wall injury or its eventual rupture. GPA was associated also with 
the iron deposition adjacent to neovessels (p=0.014), reflecting 
intramural microhemorrhages as another apparent source for 
erythrocytes (5.2.2.1).
5.4.2 Heme-derived iron may cause IA wall degeneration 
and rupture
Accumulation of erythrocytes or the fragments of erythrocyte 
cell membrane correlated with loss of SMCs (r=0.59, p<0.001), 
with IA wall degeneration (p=0.008), and with its rupture (0.005), 
suggesting a contribution of erythrocyte accumulation towards a 
rupture-prone IA wall (IV). This finding may imply the deleterious 
effect of erythrocytes in the IA wall, being in line with earlier 
findings in coronary [120,139] and carotid [165] arteries, where GPA 
accumulation associates with fragility of an atherosclerotic lesion. 
The destructive effect of erythrocytes is known to originate from their 
lysis and their subsequent release of highly oxidizing hemoglobin-
derived ferrous iron in the vascular wall [120,155,166,250,263]. Due 
to the extensive presence of GPA, it is evident that the IA wall also 
contains hemoglobin-derived ferrous iron, which may contribute to 
oxidative stress for that wall. Laaksamo et al. demonstrated oxidative 
stress in the IA wall and suggested that oxidation creates a cytotoxic 
extracellular environment leading to apoptotic cell death [133]. In 
short, a significant cause of this devastating oxidative stress in the IA 
wall appears to be erythrocytes (IV).
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5.4.2.1 Erythrocytes in the IA wall contributing to lipid oxidation 
The erythrocyte lysis products GPA (r=0.58, p<0.001, IV) and 
iron (p=0.018, II) correlated with the accumulation of oxidized 
(HNE+) lipid. Thus, erythrocyte accumulation in the IA wall may 
contribute to lipid accumulation via the retention of erythrocyte 
membrane remnants, rich in phospholipids and cholesterol, 
and also may trigger lipid oxidation via their released heme. 
GPA accumulation did not, however, associate with retention of 
apolipoproteins A-I and B-100, with adipophilin expression, or 
with the extent of neutral (ORO+) lipid accumulation (p>0.056, 
unpublished finding). This indicates that cholesterol-containing 
erythrocyte-membrane degradation is another, parallel source for 
lipid accumulation in the IA wall, one independent of lipid transport 
by apolipoproteins.
5.5 Inflammatory response to IA wall damage
Inflammatory cells had infiltrated all 44 IAs stained for such 
cells. More specifically, all of the IAs 1 to 36 contained CD163+ 
macrophages, most of the IAs contained CD68+ macrophages (34 of 
36, 94%) and CD3+ T lymphocytes (32 of 36, 89%), and a quarter of 
the IAs contained mast cells (MCs, tryptase+ cells; 9 of 36; 25%) (I). 
Single polymorphonuclear cells were also present in these IA walls, 
representing neurophils. To study the presence of inflammatory cells 
in general, samples 37 to 44 were stained only for leukocyte-common 
antigen CD45, and this was present in each of them (III). 
The observation of abundant inflammatory cells in the IA walls 
supports earlier findings suggesting the contribution of chronic 
inflammation to IA pathogenesis [47,70,116,125,244,245]. In 
atherosclerotic pathologies, as well, chronic inflammation appears 
as the driving force of remodeling of the arterial wall [143]. In the 
present study (I), among the inflammatory cells, macrophages were 
the most numerous in ruptured IAs (Table 7), and their number was 
associated with wall degeneration (wall type, Table 9). The number 
of T lymphocytes also correlated with wall degeneration. These 
findings support the earlier interpretation that chronic inflammation 
is involved in IA wall remodeling.
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5.5.1 Mast cells associated with neovessels and 
microhemorrhages
In the IA wall, MCs were rare and their number lower than for T 
lymphocytes and macrophages (Table 7). Their presence associated 
neither with wall rupture nor with wall type at a statistically 
significant level, although most of the MC-containing IAs were 
representative of the degenerated wall type C (Table 9). The rarity 
of MCs in the IA walls suggests that the role of MCs in IAs is not as 
pivotal as in atherosclerotic diseases of the extracranial arteries such 
as coronary atherosclerosis [129] and abdominal aortic aneurysms 
(AAAs) [161,234], where MCs have played an important role as 
regulators of chronic inflammation and vascular wall degeneration.
Prior to this study (I), MCs had been demonstrated in the arteries 
of the Circle of Willis in patients who had died of SAH [59], and 
more recently in samples of intraoperatively obtained IAs [83]. In 
the latter study, the authors found MCs in all ten IAs studied, and 
the semiquantitative score of MCs was higher in the five ruptured 
IAs than in the five unruptured ones [83]. This suggested MCs as 
being part of the proinflammatory response leading to IA rupture. 
Although the present finding of MCs in IAs does not support the 
hypothesis of a central role for MCs in IA pathogenesis, several 
significant IA wall remodeling changes may be facilitated by MC 
actions. 
First, all IAs containing MCs lacked intact endothelium 
(p=0.039), suggesting that the MC-specific neutral proteases 
tryptase and chymase may cause detachment of endothelial cells 
from the basement membrane of the IAs, similarly to the case in 
atherosclerotic lesions [129] and in AAAs [161]. Both proteases also 
have the ability to activate MMPs [129], capable of degrading the 
ECM. 
Second, MCs were strongly associated with the occurrence 
of neovascularization, with neovessels present in all nine MC-
positive IAs in proximity to MCs (p<0.001). The density of 
neovessels was also associated with MC occurrence (p<0.001). 
These findings suggest that MCs may induce neovascularization in 
the IA wall, similarly as in atherosclerotic plaques, aortic valves, 
and AAAs [67,107,112,161,234,236,255]. In addition to the actions 
of proteases, MCs also secrete histamine and other angiogenic 
factors such as VEGF, basic fibroblast growth factor (bFGF) [134], 
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TNF-α, and heparin [206,236], all of which may contribute to IA 
neovascularization (5.2.1.1). 
Third, MCs in the IA wall associated with and colocalized with 
microhemorrhages (p=0.003), suggesting that they may also induce 
neovessel leakage via their histamine and proteases [23,24,112,206]. 
Finally, the majority (67%) of MCs in the IA walls showed 
degranulation, suggesting that they were in the active state.
The MC proteases can also contribute to LDL modification and 
HDL degradation in the ECM, and thus trigger foam cell formation 
of the arterial wall [128,137]. In the IAs, MCs associated with the 
extent of lipid accumulation, suggesting their potential contribution 
to lipid accumulation in those IA walls where they exist. However, 
the extensive lipid accumulation compared with the minor MC 
accumulation in the IA walls implies other atherogenic mechanisms 
in the IA walls that are in general more significant than are the 
actions of MCs.
5.5.2 Inflammation directed to the clearance of 
hemoglobin
Extensive GPA accumulation correlated with the numbers of 
CD163+ and CD68+ phagocytes (r=0.65 and 0.54, p≤0.001) but 
not with the number of T lymphocytes (r=0.25, p=0.136) (IV), 
suggesting that macrophage-driven phagocytosis is a more important 
mechanism for the clearance of erythrocytes from the IA walls than 
is a potential T-lymphocyte-driven adaptive immunity response 
to erythrocytes. Macrophages are known to phagocytose intact or 
lysed erythrocytes in the arterial wall to protect it from the oxidizing 
effect of extracellular hemoglobin [140,166,186]. In addition to 
macrophages, SMCs are also capable of phagocytosing erythrocytes 
[119]. However, that a minor amount of GPA was present 
intracellularly in the IA wall may indicate either the GPA’s rapid 
lysosomal degradation after phagocytosis or indicate that phagocytes 
in the IA wall are more focused on ingesting the intracellular 
contents of erythrocytes after lysis than on ingesting erythrocyte 
membrane fragments. Hemosiderin in the IA wall reflected the prior 
phagocytosis of hemoglobin, supported also by the association of 
strong hemosiderin deposition with number of CD163+ and CD68+ 
phagocytes (p=0.016 and 0.017) (I).
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5.5.2.1 Hemoglobin-phagocytozing CD163+ macrophages in the IA 
wall
Phagocytes expressing CD163, the scavenger receptor for 
hemoglobin [130], were evident in all 36 IA walls, representing 
the most numerous type of inflammatory cells there (I). The 
massive infiltration of CD163+ cells in the IA wall appears to play 
a role in IA wall pathogenesis, since the number of CD163+ cells 
associates strongly with IA wall degeneration, (wall type, Table 9) 
and rupture (Table 7) (I), as in other studies [70,71,245]. To further 
study the phenotype of CD163+ cells in the IA wall, these cells were 
doublestained for human leukocyte-DR (HLA-DR) and aSMA (IV). 
The latter double-staining revealed only single CD163+/aSMA+ cells 
in only 3 of the 36 (8.3%) IA walls, implying that CD163+ cells were 
of myeloid origin rather than being SMC derived. Double-staining 
for four selected phagocyte-rich IAs revealed only single CD163+/
HLA-DR+ cells in one IA, showing that the main portion of the 
CD163+ macrophages were HLA-DR-. This finding suggests in IAs 
a macrophage population specialized in hemoglobin phagocytosis, 
similar to the situation suggested in atherosclerotic coronary arteries 
[26] and abdominal aortic aneurysms (AAAs) [212]. Since the IA 
wall contains much erythrocyte-derived oxidizing hemoglobin 
accompanied by infiltration of CD163+ cells, it is likely that a similar 
hemoglobin-induced macrophage population plays an important role 
in IA pathogenesis. 
5.5.2.2 Hemeoxygenase-1 involved in IA pathogenesis
The vast majority of the 36, 35 (97%), expressed 
hemeoxygenase-1 (HO-1), and its expression was significantly higher 
in degenerated IAs (p=0.041, IV). This finding is in line with the 
observation of HO-1 expression as being higher in ruptured than in 
unruptured IAs [133]. CD163+-mediated phagocytosis of hemoglobin, 
usually complexed with the circulating acute-phase protein 
haptoglobin, leads to degradation of the complex in lysosomes and 
subsequent degradation of the protoporphyrin ring of heme by HO-
1. This reaction produces anti-inflammatory carbon monoxide and 
biliverdin, along with the ferrous iron [172,220]. HO-1 in the IA 
wall and its correlation with extensive GPA accumulation (r=0.57, 
p<0.001) thus reflects the degradation of hemoglobin in the IA wall. 
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Both oxidative stress and hemoglobin upregulate HO-1 expression 
[100,187]. High HO-1 expression correlated with the numbers of 
CD163+ and CD68+ macrophages in the IA wall (r=0.74 and 0.67; 
p<0.001 for both), suggesting that inflammatory cells likely express 
HO-1 there. Moreover, of 28 IA walls, half showed solitary SMCs 
expressing HO-1 (IV), an observation in line with earlier findings in 
AAAs [212].
5.5.3 Inflammation directed to the clearance of lipids
The presence of apoB-100, oxidized lipid, and adipophilin was 
associated with high numbers of CD68+ and CD163+ macrophages 
(r=0.564-0.695, p<0.001 for each), suggesting that excess lipid load 
is proinflammatory and widely handled by phagocytosis in the IA 
wall (II), as it is in atherosclerosis [80]. Phagocytes expressing the 
pan-macrophage scavenger receptor CD68 were the second most 
numerous cells of inflammatory cells in the IA wall (I). Generally, 
CD68 action is not significant in tissue response to bacterial or viral 
pathogens [44], but CD68 has a high affinity for oxidized low-density 
lipoprotein particles and apoptotic cells, thus showing its importance 
in the atherosclerotic inflammatory processes of arterial walls [247]. 
In the IA wall, the CD68+ phagocyte was the dominant foam-cell 
type in the majority (20 of 36) of IA walls in comparison to aSMA+ or 
to CD163+ cells (II). Moreover, foam cells in human atherosclerotic 
plaques have shown a predominance of CD68 over CD163 expression 
[247]. Therefore, CD68+ macrophages appear important in the 
primary clearance of lipids from IA walls, as important as they are in 
atherosclerotic walls.
In addition to foam cells, all IA walls expressed HLA-DR (IV), 
the major histocompatibility complex class II protein responsible for 
antigen presentation to T-lymphocytes after phagocytosis [81]. The 
finding that extensive HLA-DR expression in the IA wall correlated 
with extensive lipid accumulation: apoB-100, oxidized lipid, and 
adipophilin (r=0.455-0.522, p£0.005), means that lipid intake is 
likely one of the triggers of HLA-DR expression in the IA wall. The 
extensive expression of HLA-DR also correlated with high numbers 
of CD68+ (r=0.525, p=0.001) and CD163+ (r=0.422, p=0.012) 
macrophages, and T lymphocytes (r=0.413, p=0.012), suggesting 
their involvement in the acquired immunity response to lipid 
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clearance from the IA wall. Interestingly, double-stainings revealed 
that also solitary SMCs, in addition to macrophages, expressed 
HLA-DR, which may reflect their adaptation to lipid-ingesting cells, 
similar to the situation in atherosclerotic plaques [81,109]. 
Adaptive immunity is potentially involved in the protection of the 
IA wall from atherosclerotic processes also humorally, because in 
patients carrying unruptured IAs, serum levels of immunoglobulin 
G antibodies reactive to oxidized lipids are higher than in patients 
with a history of aneurysmal SAH [72]. In IAs, as well, oxidized lipids 
may activate the complement system in the presence of CRP [244], 
as they do in atherosclerosis. In addition, the majority of naturally 
occurring IgM antibodies are capable of binding to oxidized epitopes, 
activating the complement system [45], and they are detectable 
in IAs [47,244]. The humoral or other mechanisms of adaptive 
immunity were not further assessed in this study, but, based on the 
presence of T lymphocytes and HLA-DR in the IA wall, adaptive 
immunity is likely an important support for innate immunity in lipid 
clearance from the IA wall. 
5.5.4 Possible role of macrophages in the IA wall
Degenerated IA walls appear to suffer from a load of waste 
material, such as lipids, lipoprotein particles, and erythrocyte-
remnants including toxic hemoglobin-derived iron. The fundamental 
role of macrophages is to protect tissues by phagocytozing pathogens 
and other foreign material from disturbed area and thus supporting 
the tissue’s physiological function [101]. To effectively prevent the 
retention of harmful material in the arterial wall is the reason for the 
existence of various subpopulations of macrophages [41,50]. 
Human macrophages commonly express CD68 and may 
co-express CD163 as a response to hemoglobin ingestion 
[66]. Traditionally, macrophages have been classified into 
proinflammatory M1- and anti-inflammatory M2 subtypes. Of these, 
the M1 type is activated through Th1 and is predominantly CD68+, 
whereas the M2 type is activated through Th2 and is predominantly 
CD163+ [41,66,175]. However, the M1/M2 classification of 
macrophages may be too much simplified, due to the existence of 
a dynamic range of differing macrophage subtypes in the human 
vasculature [66,175,247]. 
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Finn et al. have demonstrated in cultured human monocytes that 
monocytes exposed to hemoglobin-haptoglobin complexes express 
CD163, showing resistance to lipid accumulation by upregulating 
ABCA1 [66]. This hemoglobin-induced population was further 
characterized as a hemorrhage-induzed macrophage population 
[26]. In atherosclerotic plaques, these “non-foamy” macrophages 
were suggested to have locations distinct from CD68+ macrophages, 
suggesting separate macrophage populations induced by stresses of 
the local microenvironment [66].
Based on the findings of erythrocytes, microhemorrhages, 
lipids, and foam cells in the IA wall, it seems likely that similar 
mechanisms of macrophage polarization may occur also in the IA 
wall. Most likely, the IA-wall phagocyte population also includes 
a variety of different macrophage populations with different, but 
partly overlapping subspecializations. The defensive functions of 
macrophages in the clearance of lipids and other waste products 
appear to be supplemented by those of inflammation-adapted 
SMCs, potentially to compensate for the insufficient function of 
macrophages. Thus, the essential role of macrophages would be the 
protection of mural SMCs from toxic lipid- and erythrocyte waste, 
which may thus be the primary cause of IA wall degeneration and 
rupture, rather than the cause as being the inflammatory response 
itself. Therefore, especially the widespread infiltration of the CD163+ 
macrophages strongly associated with IA wall degeneration and 
rupture may indicate the potentially destructive effect of erythrocyte 
accumulation in the IA wall.
5.6 Hemodynamic models and IA remodeling
A subseries of 11 unruptured and 9 ruptured IAs was studied 
with CTA-derived flow simulations for any correlation between 
histopathological changes and intraluminal hemodynamic conditions 
(III). Of the IAs, 4 showed high wall-shear stress (WSS), 7 showed 
low WSS, and 9 mid-WSS. Neither WSS nor other hemodynamic 
variables (viscous dissipation, VD, oscillatory shear index, OCI, flow 
complexity, or flow instability) differed between unruptured and 
ruptured IAs. However, flow conditions were associated with IA wall 
structural remodeling and inflammation.
Figure 19. Inflammatory cell infiltration in the Ia wall: a, tryptase+ cells, i.e. mast cells; b, CD3+ T lymphocytes; c, 
HLA-DR+ inflammatory cells; d, CD163+ macrophages. E and f show accumulation of GPA in the IA 
wall, indicating erythrocytes or their cell membrane fragments. In e, an unruptured and in f, a ruptured 
IA wall. These images demonstrate erythrocytes in the IA wall independent of IA-rupture status. 
CD163+ macrophages were mainly HLA-DR- in the IA wall, suggesting the hemoglobin-phagocytozing 
phenotype detectable in AAAs and coronary arteries. 
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5.6.1 Flow conditions and IA wall remodeling 
In the flow-modeled IAs, simple and stabile flows were associated 
with the 10 type-B walls, indicating the association of such flow 
conditions with hyperplastic IA walls. In contrast, slow and 
diffuse flows were associated with the 8 type-C walls, meaning a 
degenerated, decellularized IA wall structure. Type-B and -C walls 
also showed a lower OCI than did the 2 type-A walls, suggesting 
that a less transient flow associated with wall remodeling, whereas 
multidirectional flows associated with a more linearly organized IA 
wall composition. 
Flow conditions have been studied in a mouse carotid artery by 
means of a surgically created stenosis [40,191]. In that model, Cheng 
showed that low and oscillatory WSS induces atherosclerotic plaque 
formation, whereas particularly low WSS induces large, outward, 
and vulnerable lesions, but oscillatory shear stress induces more 
stabile lesions with fibrous caps and a proliferation of SMCs [40]. 
Pedrigi further demonstrated, in the same mouse model, that the 
low-WSS-induced vulnerable plaques were located in the prestenotic 
region of the artery, whereas the complex flow-induced advanced 
plaques were located in the post-stenotic region of the artery [191]. 
Apparently, the experimental model of a stenotic artery is not 
geometrically applicable to the outwards-pouching IA, which can 
present with a variety of different morphologies. However, based on 
the variable geometries, histological findings, and flow parameters, 
it could be assumed that similar flow-induced areas were present 
regionally in the IA wall. Thus, the different regional flow patterns 
in the IA lumen, affected by the geometrical shape of the IA pouch, 
could affect histology in specific regions of the wall.
5.6.1.1 Flow, endothelial erosion, and inflammation in the IAs
The condition of the endothelium was analyzed from 10 flow-
modeled IAs, of which 7 lacked intact endothelium. Defective or 
absent endothelium was associated with non-physiological flows 
such as low OCI, high vorticity, high VD, and high shear rate 
(p=0.020-0.034). Functioning as a barrier between the arterial 
wall and the circulation, the endothelium is sensitive to changes in 
blood flow which affect the morphology, alignment, and function 
of endothelial cells [54,207]. The altered flow conditions in the 
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IA lumen may trigger an endothelium-driven proinflammatory 
signaling cascade [246]. Pedrigi et al. simulated in vitro how 
a multidirectional (oscillatory) endothelial cell stretch caused 
increased expression of the proinflammatory mediator NF-kB in 
the stretched cells [190]. Flow-induced inflammation mediated 
by NF-kB has been demonstrated in a rodent aneurysm model, 
and a similar mechanism has been proposed to occur also in 
human IAs [14]. It is likely that the barrier mechanism of the 
luminal endothelium in the IAs has become disturbed due to the 
nonphysiological flow, which could also have triggered endothelial 
loss and inflammation.  
Similar to an endothelial defect, inflammation in the IA walls 
was associated with high vorticity, high VD, and high shear rate 
(p=0.046 for all). Those IAs with low or high WSS showed a greater 
number of CD45+ inflammatory cells than did the IAs with mid-WSS. 
Variability in CD45+ cell distribution was associated with WSS levels 
in different areas of the IA sac (p=0.035), supporting the possibility 
that focal WSS level may play a role in that area’s inflammatory cell 
infiltration. 
5.7 Visualization of erythrocyte remnants with 
MRI
In MRI, hemosiderin causes a hypointense signal or signal loss, 
i.e. a susceptibility artifact [60]. Honkanen et al. demonstrated 
in three giant IAs their MRI sensitivity for Prussian blue-positive 
iron [91]; in the current study (IV), eleven small IAs were similarly 
imaged with MRI, using two iron-sensitive sequences [91].
All 11 IAs showed susceptibility artifacts in both T2*-weighted 
(FLASH) and T2-weighted (RARE) sequences. Their histology 
showed in all these IAs also hemosiderin deposition, and 10 showed 
GPA+ staining; the orientation of 9 IAs was identifiable in MRI, and 
these were thus included in the histologic comparison. After the 
correlation of histological specimens with their corresponding MR 
images (in total 48 MRI-slice-histological section pairs; 3 to 9 per 
IA), no exact spatial correlation of histology with distribution of the 
MRI signal in that slice was, however, identifiable.
Challenges in identifying the corresponding specific wall areas 
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in each MR image and its histological section were in part related 
to MRI-signal heterogeneity; this did not provide a specific signal 
pattern in the corresponding histological region of interest, i.e. a 
GPA+- or iron+ area of the wall. Furthermore, the smaller sample size 
of the present IAs in comparison with the earlier series of giant IAs 
(median length 11 vs. 40 mm and width 10.5 vs. 30 mm) [91] may 
have predisposed unintentional changes in IA sample orientation 
in MRI and histology during sample processing, thus further 
challenging accurate spatial comparison. 
Due to current limitations, all MRI and histological section 
pairs were compared, also irrespective of spatial analysis. 
Interestingly, extensive GPA accumulation correlated positively with 
a hyperintense (bright) signal in both RARE (r=0.444, p=0.004) 
and FLASH (r=0.519, p=0.001) sequences of MRI presentation, 
whereas extensive hemosiderin deposition correlated positively 
with hypointense (dark) signal (r=0.373, p=0.015, Spearman) and 
negatively correlated with a hyperintense signal (r=-0.404, p=0.008) 
in the RARE sequence of MRI. 
To conclude, this study did not succeed in demonstrating the 
erythrocyte degradation products in MRI of the IA wall. However, 
the statistical association found between MRI signal intensity and 
the presence of erythrocyte degradation products in the IA wall 
implies that further studies, potentially utilizing high-resolution 
MRI, could provide more knowledge on the relevance of MRI in 
visualizing IA wall erythrocyte accumulation and microhemorrhages. 
Matsushige et al. recently imaged 7 giant IAs in vivo with 7T MRI, 
showing high spatial resolution which also allowed visualization of 
IA wall microstructure [157]. In histological evaluation of 2 of the 
giant IAs, Prussian blue-positive hemosiderin was located in the 
adventitial layer and also in the luminal region of the wall adjacent 
to the thrombus. These same areas showed a hypointense signal 
in time-of-flight (TOF)-MRA and susceptibility-weighted imaging 
(SWI) sequences, demonstrating that the MRI presentation can show 
iron deposition [157]. Thus, high-field MRI up to 7T, in comparison 
to lower magnetic fields, may serve as a sensitive method for IA wall 
imaging iron deposition. Wrede et al. compared the images acquired 
between 7T MR angiography and standard digital subtraction 
angiography (DSA) in 64 unruptured IAs, proposing the combination 
of TOF-MRA and magnetization-prepared rapid acquisition 
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gradient-echo sequences as a promising clinical application for 
imaging of IAs [257].
Collectively, it appears that MRI techniques have the potential 
for detailed imaging of IA structure. As the availability of high-field 
MRI increases, promisingly also smaller IAs can be visualized. Thus, 
MRI may serve as a tool for evaluating the individual-IA rupture 
risk, more specifically than does current risk analysis based on IA 
size, shape, or growth in follow-up. However, first the meaning of 
various different signal intensities and visualizing enhancements, 
whether the biomarker of interest is tissue iron or something 
else, and whether a contrast agent should be used or not, call for 
elucidation. Histological studies are essential tools to be coupled 
with radiological imaging in future studies. 
5.8 Limitations of the study
For this series of IAs, several limitations should be 
noted.
Challenges of IA sample collection 
Obtaining IA sample tissue material is always limited. First of 
all, only a portion of all IAs are treated surgically, and those treated 
endovascularly do not allow any aneurysm tissue sampling. Nor 
during surgery do circumstances always allow sample collection. 
The smallest IAs cannot be collected after clipping due to 
insufficient amount of tissue. Closed with a clip, the neck region of 
an IA remains in the patient. The present series is therefore quite 
selected and restricted to those IAs that could be collected with 
consideration of patient safety and IA size.
Histological autopsy studies of small IAs may be able to 
supplement the histological analysis, but factors potentially 
important in IA pathogenesis may be undetectable after death due 
to tissue autolysis.
Avoiding sample selection bias when using perioperative or 
other in vivo IA tissue collection techniques is impossible. To 
study also the wall composition of the smallest IAs, ones likely 
representative of very early lesions or pre-IAs, will require 
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development of detailed imaging methods such as high-field 
MRI. Once enough data exist on visualization of histological 
changes in imaging studies, it may be possible to extrapolate from 
comparisons of histological and imaging studies of large IAs to the 
smallest ones. 
Small number of samples 
The small series of IAs is, naturally, a shortcoming in terms 
of weak statistical power, sensitivity to bias, and the likelihood of 
selection and other confounding coincidences. However, collection 
of a large IA series is challenging and time-consuming. Although it is 
important to study large IA series to ensure increased the statistical 
power of the potential findings, smaller series can provide important 
new data in a feasible length of time.
Time progress of IA pathogenesis remains unknown
Sample collection is only one moment in time which does 
not reveal the slow dynamic wall remodeling process that, at the 
moment of sample resection, may have already lasted years or 
decades. Thus, the natural history of IAs is still poorly known. To 
follow the pathogenesis of an IA through histology would require 
regular biopsies or other methods of tissue collection, all of 
which are impossible; thus the chronological order of histological 
changes in the IA wall remains unknown. For the same reason, 
control tissue from the patients’ intracranial arteries is rarely, if 
ever, available. Importantly, the present research does not reveal 
causative mechanisms in IA pathogenesis. 
To further study the causal connections involved in IA 
pathogenesis and to place events in a time-line of pathogenesis 
warrants the best possible experimental models representing 
human pathogenesis. Meanwhile, when assessing the rupture 
probability of these human IAs, it seems valuable not to rely 
only on the known rupture status of a particular IA, since the 
walls of unruptured IAs may also be rupture-prone. IAs that still 
were unruptured at the moment of sample collection might have 
ruptured the following day. Finding those features which may 
predict wall rupture is therefore vital. 
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Clinical data may be outdated
The amount of clinical information available concerning each IA 
patient’s risk factors may vary greatly. Here, the clinical data were 
collected retrospectively from patient medical records which did not 
always reveal for all patients current or accurate data on smoking 
status, blood pressure, or cholesterol levels. These are shortcomings 
that can affect results and final interpretations as to clinical 
correlations with IA wall histopathology. 
One solution for improvement of clinical data collection would 
be a prospective questionnaire and accurate IA measurements. 
However, this type of data collection would still miss those patients 
entering a hospital with acute aneurysmal SAH and receiving 
emergency surgery for a ruptured IA.
Simplification	of	heterogenous	IA	wall	structures
Histological analyses were in almost all cases performed at only 
one sample-section level of the IA block. Since wall composition 
may be highly heterogenous within one IA, the location of many 
degenerative factors may also vary within the IA wall. In addition, 
there may even exist different areas representing different wall types 
within a single IA section. In those cases, the sample was classified 
according to the dominant (i.e. the most apparent) wall type. 
Another option would be to study several histological parameters 
based on a focal representation of a certain wall type, resulting in 
several subanalyses for various wall types within one IA sample. This 
method would have given more detailed data on wall-type-based 
histologal parameters; it would not, however, have allowed inter-
sample analysis and comparisons.
Since no two IA walls are identical, evaluation of individual 
IAs through imaging and possibly other detailed methods should 
allow assessment of their individual rupture risks. Histological-
sample analysis regionally should find the weakest spot of the wall, 
which could determine the fate of the entire wall. As knowledge of 
the histological markers of IA wall fragility accumulates, finding 




In the histological sections, the actual rupture site in ruptured 
IAs was neither sought nor identified. The exact orientation of 
any IA sample during its mounting and freezing and its placement 
in the cryotome is, indeed, challenging. The site of rupture in 
the IA macroscopic inspection is not always definite, either. In 
comparison with an atherosclerotic lesion, an IA may not clearly 
show any specific region of interest such as the shoulder region in 
an atherosclerotic plaque. It is most likely, however, that the rupture 
site is included in the collected IA sample specimen, since Crompton 
showed already in the 1960s in an autopsy study of 289 SAH patients 
that most often (84%) an IA ruptures through its apex i.e. the IA 
fundus [51]. This suggests that in surgically acquired samples, the 
rupture site will be included in the sample studied.
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6 Conclusions
1) Mast cells (MCs) appear in only a minority of IA walls, and 
when they do, they are scanty. The role of MCs is thus, in 
general, likely less important in IAs than in extracranial 
atherosclerotic diseases, where they are important regulators 
of vascular wall atherogenesis and inflammation. Pro-
angiogenic factors of MCs may, however, in this fraction of 
IA walls contribute to IA wall neovascularization, detectable 
in nearly half of the walls. Neovessels were associated 
with hemosiderin deposition, implying their leakiness 
and subsequent microhemorrhages, which may release 
hemoglobin-derived pro-oxidative iron in the sIA wall. 
MC proteases are one potent factor that may contribute to 
rupture of neovascular newly formed endothelia in sIA walls, 
thus increasing the likelihood of deleterious intramural 
microhemorrhages.
2) Lipids accumulate in all IA walls, which also show 
accumulation of circulatory apoliporoteins. Lipid transport 
by pro-atherogenic apoB-100-containing lipoprotein 
particles seems likely to be the major mechanism for 
IA-wall lipid entry. The macrophages and SMCs in the 
IA wall show foam cell formation, suggesting clearance 
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of lipids via phagocytosis. Lipids that have once been 
phagocytosed, however, appear to end up back in the IA 
wall’s extracellular space, a phenomenon associated with wall 
rupture. That finding, together with the finding of abnormal 
accumulation of normally anti-atherogenic apoA-I, suggests 
the contribution of an impaired ABCA-1–apoA-I-mediated 
cellular lipid clearance to lipid-laden foam cell death. Such 
cytotoxic intracellular and extracellular lipid accumulation 
may thus contribute to IA wall rupture.
3) IA intraluminal hemodynamic conditions are associated 
with wall remodeling and inflammation. These wall changes 
may, at least in part, be mediated by endothelial cells that 
are responsive to vascular-wall shear stress. Pathological 
flow factors in IAs, obtained from CT-angiography-derived 
hemodynamic simulations, may serve as a marker for IA wall 
degeneration, and are thus a potential tool for diagnostics of 
rupture-prone IAs. 
4) Erythrocyte-membrane-component GPA accumulates in 
degenerated IA walls independent of IA rupture status, 
implying chronic accumulation of erythrocytes in IA walls. 
The extent of such accumulation associates with IA wall 
rupture, suggesting the deleterious effect of erythrocyte 
breakdown products. Iron-containing hemoglobin, 
released from lysed erythrocytes, is pro-oxidative and pro-
inflammatory. CD163+/HLA-DR- phagocytes are abundant 
especially in degenerated and ruptured IA walls suggesting a 
macrophage population specialized in hemoglobin clearance 
there. A macrophage-derived product of hemoglobin, 
hemosiderin is detectable by MRI. Here, both hemosiderin 
and GPA were associated with signal intensity changes in 
ex vivo MRI, suggesting their role as promising biomarkers 
for diagnostics of rupture-prone IAs. Neither the areas of 
hemosiderin accumulation nor those of GPA accumulation 
were, however, spatially identifiable in ex vivo MR images, 
suggesting that imaging of small-sized IAs requires further 
development of methods prior to any clinical application.
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7 Summary
The subarachnoid hemorrhage (SAH) is a highly fatal disease 
threatening all who harbor saccular intracranial aneurysms (IAs). 
Rupture of the IA wall occurs due to a complex process of IA 
wall degeneration that tissue-protection mechanisms failed to 
repair. Only a fraction of IAs rupture during a lifetime, but timely 
identification of those IAs prone to rupture and demanding surgical 
or endovascular treatment remains a clinical challenge. Known 
clinical risk factors for IA formation and rupture, including smoking 
and high blood pressure, suggest a role for vascular risk factors 
in IA-wall pathogenesis. Non-physiological blood flow conditions 
contribute to the formation of atherosclerotic plaques, and likely 
also of IAs, both typically located in arterial bifurcations. This thesis 
evaluated the potential role and imaging of hemodynamics and 
atherosclerotic changes in IAs.
Histopathology of the IAs studied represented a variety of 
structural wall-remodeling changes accompanied by thrombosis, 
chronic inflammation, and accumulation of lipids, in line with 
earlier IA series. These changes were associated also in this series 
with IA wall degeneration and rupture, demonstrating their clinical 
importance. The majority of the IAs showed endothelial erosion 
indicative of loss of the intraluminal barrier. 
The endothelial erosion was associated with an abundance 
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of accumulated circulatory apoB-containing LDL- and other 
atherogenic lipoproteins. Thus, dysfunctional endothelium may 
allow increased lipid influx from the circulation into the IA wall 
as in atherosclerotic diseases. Degenerated IAs showed extensive 
retention of neutral and oxidized lipids. Especially the extracellular 
space of degenerated and ruptured IA walls contained an abundance 
of once-phagocytozed lipid material, likely derived from dead 
macrophage- and smooth-muscle-cell foam cells. HDL-mediated 
cellular lipid clearance by the apoA-I-ABCA-1-pathway seemed 
to occur in the IA wall, but most likely functioned inefficiently. 
Accumulation of cytotoxic lipid in the IA wall may therefore be a 
potent mechanism of IA degeneration and rupture. 
Degenerated and ruptured IA walls also showed the 
widespread erythrocyte-membrane component GPA, reflecting 
wall accumulation of intact erythrocytes or erythrocyte membrane 
fragments. Organized intraluminal thrombus appeared as the major 
source of GPA and may thus chronically induce oxidative stress in 
the IA wall, via the release of hemoglobin from lysed erythrocytes. 
Neovessels appeared as another potential source of erythrocyte 
leakage, since some fraction of the IAs showed adjacent iron 
deposition indicative of microhemorrhages. The role of erythrocyte 
waste material in the IA wall is potentially deleterious, due to the 
accumulation of cholesterol-rich atherogenic cell membranes and 
oxidative heme-derived iron.
A pro-oxidative environment and the presence of hemoglobin 
were considered to be pro-inflammatory in the IA wall, because 
among inflammatory cells, macrophages expressing hemoglobin-
haptoglobin scavenger receptor CD163+ were most frequent in 
the wall. Their predominance in the IA wall may result from 
their upregulation in the presence of hemoglobin, similarly as 
in atherosclerotic plaques and AAAs. In the IAs, a high number 
of CD163+ cells associated strongly with wall rupture. CD68+ 
macrophages also associated with degeneration and rupture, likely 
playing an important role in the inflammatory response to clearance 
of various excess substances from the wall. T lymphocytes may 
have played some role in the adaptive immunity response in the IA 
wall, although their identities were not further specified in the this 
study. Mast cells were present in the areas of neovascularization 
and microhemorrhages, indicating their proangiogenic potential 
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and their adverse effect on neovascular endothelium in the IA wall, 
similar to that of atherosclerotic lesions. However, the scattered 
presence of MCs in only some of the IAs suggest their minor role in 
IA pathobiology. 
In sum, atherogenic processes are apparently present in IAs, 
indicating that IAs may show mechanisms of degeneration and 
inflammation similar to those of atherosclerotic lesions. These 
mechanisms may contribute to IA wall rupture.
Both imaging methods utilized here: computational fluid 
dynamics and ex vivo MRI, showed changes in correlation with some 
IA wall changes. Intra-aneurysmal flow models suggested abnormal 
wall-shear stress in the IA wall as a potential trigger of degenerative 
changes and inflammation, hypothetically mediated by endothelial 
injury. Non-contrast ex vivo MRI appeared promising in visualizing 
degenerative IA wall changes. Finding a relevant marker of high 
sensitivity and specifity for IA rupture risk requires, however, further 
work. This study will be, hopefully, of aid in guiding future studies, 
and development of novel diagnostic methods and preventive 
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